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 The goal of this dissertation is to establish the environmental and public health 
importance of alternative forms of antimicrobial therapy, specifically those that utilize 
nanotechnology to combat quorum sensing-controlled bacterial infections. Quorum 
sensing (i.e. chemical communication) is an inherent characteristic that is essential to 
bacterial pathogenesis and biofilm formation (where most infections occur). A thorough 
review of the literature has been conducted to establish an understanding of the state of 
nanotechnology research as it relates to combatting bacterial infections. This synthesis, 
provided in Chapter 1, demonstrates how the chemical and structural designs of 
nanoparticles can be manipulated to specifically target bacterial infections.  
 Next, an investigation into the development and novel use of nanoparticles 
engineered to shut down bacterial quorum sensing is given in Chapter 2. Inhibiting the 
quorum sensing process is significant because it does not kill the bacteria, and therefore 
does not exacerbate antibiotic resistance. Briefly, the model system demonstrates that -
cyclodextrin functionalized nanoparticles are able to persist in the bacterial cell 
environment and quench extracellular bacterial communication molecules, and 
effectively silence bacterial communication. The system neutralizes communication 
through chelation of common signaling molecules called acyl-homoserine lactones. The 
new technology described here provides a seminal step in developing anti-virulence 
therapies that will not contribute to antibiotic resistance, and do not rely on traditional 
vi 
antimicrobials.  Also, this technology utilizes non-toxic nanoparticles that can be 
functionalized with biologically-active compounds and tailored to meet specific needs.  
This study provides a scaffold and critical stepping stone that will promote more-tailored 
future developments in nanoparticle-based antimicrobial therapy.  
 Chapter 3 provides insight into the environmental importance of bacterial 
communication, and the steps taken by bacteria to protect the valuable signal molecules.  
Briefly, environmental biofilms consist of extracellular polymeric substances with a high 
concentration of nonreducing sugars, such as trehalose. Previous studies have shown that 
trehalose is commonly utilized by soil bacteria during periods of drought to maintain 
membrane stability and preserve the structure of proteins.  The study presented in 
Chapter 3 demonstrates that trehalose plays a role in protecting quorum sensing signals 
during desiccation through the formation of an extracellular glass. Additionally, the study 
provides a survey of the complexity of microbial ecosystems and the role that biofilm 
components play in the natural environment. Together, the three chapters of this 
dissertation demonstrate the importance of quorum sensing to bacteria and as a target for 
nanoparticle-based antimicrobial therapy.  
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TABLE OF CONTENTS 
DEDICATION ....................................................................................................................... iii 
ACKNOWLEDGEMENTS ........................................................................................................ iv 
ABSTRACT ............................................................................................................................v 
LIST OF TABLES .................................................................................................................. ix 
LIST OF FIGURES ...................................................................................................................x 
CHAPTER 1: ENGINEERED NANOPARTICLES TO ATTACK BACTERIA .....................................1 
 1.1 NANOPARTICLES AS DRUG CARRIERS: A BRIEF HISTORICAL PERSPECTIVE ..............2 
  
 1.2 THE ANTIBIOTIC DILEMMA: THE MODE OF DELIVERY COUNTS ................................3 
 
1.3 DIRECT AND INDIRECT ANTIMICROBIAL PROPERTIES OF INORGANIC 
NANOPARTICLES ........................................................................................................15 
 
1.4 LINKING ANTIBIOTICS TO INORGANIC NANOPARTICLES: CHALLENGES IN SURFACE 
CHEMISTRY DESIGN ....................................................................................................25 
 
 1.5 OVERCOMING THE BACTERIAL BARRIERS OF INFECTIONS: NANOPARTICLES AS 
ANTIMICROBIAL DELIVERY VEHICLES ........................................................................45 
  
 1.6 CONCLUSION .......................................................................................................53 
 
CHAPTER 2: FUNCTIONALIZED NANOPARTICLES SILENCE BACTERIAL COMMUNICATION ....61 
 2.1 CHARACTERIZATION OF MONOLAYER NANOPARTICLES .......................................63 
 2.2 CHARACTERIZATION OF POLYMER NANOPARTICLES ............................................64 
 2.3 NMR DETECTS BINDING OF HSLS AND -CYCLODEXTRIN ..................................64 
 2.4 -CYCLODEXTRIN QUENCHES HSLS IN VITRO ......................................................67 
 2.5 TRANSCRIPTION OF THE LUX OPERON DURING NANOPARTICLE EXPOSURE ...........69
viii 
 2.6 CONCLUSION .......................................................................................................71 
 2.7 METHODS ............................................................................................................73 
CHAPTER 3: EXTRACELLULAR GLASS WITHIN THE EPS MATRIX IS A PROTECTIVE STRATEGY 
FOR BIOFILMS AGAINST DESICCATION .................................................................................92 
  
 3.1 RESULTS ..............................................................................................................97 
 3.2 DISCUSSION .......................................................................................................106 
 3.3 CONCLUSION .....................................................................................................108 
 3.4 MATERIALS AND METHODS................................................................................109 
REFERENCES .....................................................................................................................124
ix 
LIST OF TABLES 
Table 1.1 Description of major endocytosis pathways ......................................................54 
 
Table 2.1 Measured and corrected diffusion coefficients (D) for various mixtures of     
C8-HSL and cyclodextrin. .................................................................................................78 
 
Table 2.2 Binding strength of -CD and C6-HSL or C8-HSL as determined by NMR ....78 
 
Table 2.3 Calculated fold change of transcription by V. fischeri after treatment exposures 
to 125 nM 3OC6- and 0.25 nM C8-HSLs ..........................................................................79 
 
Table 2.4 Primer sequences used in qPCR ........................................................................79 
 
Table 3.1 Composition of sugar monomers within EPS extracted from natural mats .....113 
 
Table 3.2 C6-AHL activity in trehalose as determined by pigmentation response of        
C. violaceum CV026. .......................................................................................................114 
 
Table 3.3 Acylase activity in sugar after heat treatment ..................................................114 
  
x 
LIST OF FIGURES 
Figure 1.1 Diagram of cell walls of Gram-positive and Gram-negative bacteria ..............54 
 
Figure 1.2 Schematic illustration showing the loading and release mechanism of an 
anionic drug in TA modified MSN ....................................................................................55 
 
Figure 1.3 (a) Schematic illustration showing the controlled drug release of a pNIPAAm-
grafted Au nanocage; (b) Atom-transfer radical polymerization of NIPAAm and acrylic 
amide monomers ................................................................................................................56 
 
Figure 1.4 Major endocytosis pathways ............................................................................57 
 
Figure 1.5 Schematic illustration of multidrug release by MSN-polymer  
nanocomposite ...................................................................................................................57 
 
Figure 1.6 Schematic illustration of the synthesis of DOX-associated Fe3O4 nanoparticles 
coated with a PEG modified porous silica shell ................................................................58 
 
Figure 1.7 Schematic illustration of the synthesis of core-shell drug delivery vehicle .....59 
 
Figure 1.8 Schematic illustration showing the one-pot self-assembly strategy for 
synthesis of drugs@micelles@MSNs ................................................................................59 
 
Figure 1.9 Schematic of biofilm encased in extracellular polymeric secretions ...............60 
 
Figure 2.1 N-acyl homoserine lactone ...............................................................................80 
 
Figure 2.2-cyclodextrin chemical (A) and toroidal (B) structure ...................................80 
 
Figure 2.3 Schematic representation of monolayer -CD coated fluorescent silicon 




H NMR spectra of the as-synthesized -CD coated silica nanoparticles ........81 
 
Figure 2.5 TGA of (a) dye-labeled monolayer carboxylic acid coated silica nanoparticles; 
(b) dye-labeled monolayer -CD coated silica nanoparticles ............................................82 
 
Figure 2.6 Schematic representation of a polymer grafted silica nanoparticle with -CD 
side group ...........................................................................................................................83 
xi 
Figure 2.7 TGA of (a) dye-labeled poly(methacrylic acid) grafted silica nanoparticles; (b) 
dye-labeled poly(-CD) grafted silica nanoparticles .........................................................84 
 
Figure 2.8 Photograph of dye-labeled poly(-CD) grafted silica nanoparticles in  
DMSO ................................................................................................................................85 
 
Figure 2.9 N-Acyl homoserine lactone molecules synthesized and recognized by  
V. fischeri ...........................................................................................................................85 
 
Figure 2.10 V. fischeri JB10 cultures in marine broth. Bioluminescence induced with 
3OC6-HSL and C8-HSL ....................................................................................................86 
 
Figure 2.11 Maximum relative bioluminescence per OD (600 nm) of V. fischeri during 
exposure to -CD and 2 μM 3OC6-HSL ...........................................................................87 
 
Figure 2.12 Schematic of nanoparticle-based silencing of bacterial quorum sensing .......88 
 
Figure 2.13 Changes in bioluminescence by V. fischeri during exposures to 2 μM 3OC6-
HSL, with either -CD or -CD functionalized Si-NPs ....................................................89 
 
Figure 2.14 Maximum relative bioluminescence per OD (600 nm) of V. fischeri during 
exposure to 2 μM 3OC6-HSL and -CD or -CD functionalized 15 nm polymer 
nanoparticles ......................................................................................................................90 
 
Figure 2.15 Mean relative bioluminescence per OD (600 nm) of V. fischeri during 
exposure to 125 nM 3OC6-HSL and 0.25 nM C8-HSL treated with 250 nM -CD, bare 
15 nm Si-NPs, 155 nM -CD functionalized 15 nm Si-NPs, bare 50 nm Si-NPs, or 133 
nM -CD functionalized 50 nm Si-NPs .............................................................................91 
 
Figure 3.1 Natural microbial mats collected from Salt Pond on San Salvador Island, 
Bahamas showing wet- (A) and dry- (B, C) season sections of mat surface ...................115 
 
Figure 3.2 SEM of dried surface layer of microbial mat .................................................116 
 
Figure 3.3 TEM of dry, natural microbial mats showing intact cells surrounded by a 
dense capsular layer of EPS .............................................................................................116 
 
Figure 3.4 Vertical cross-section of microbial mat in Salt Pond showing distinct layering 
of microbial groups ..........................................................................................................117 
 
Figure 3.5 Abundances of EPS isolated from surface layers of hypersaline mat in Salt 
Pond, San Salvador Island, Bahamas ...............................................................................117 
 




Figure 3.7 DSC thermogram recorded upon heating of trehalose anhydrous at rate of 
10°C/minute .....................................................................................................................119 
 
Figure 3.8 DSC thermogram recorded upon heating of Salt Pond EPS at rate of 
10°C/minute .....................................................................................................................120 
 
Figure 3.9 TGA thermogram of trehalose dihydrate recorded upon heating at rate of 
10°C/minute .....................................................................................................................121 
 
Figure 3.10 TGA thermogram of Salt Pond EPS recorded upon heating at rate of 
10°C/minute .....................................................................................................................122 
 
Figure 3.11 Solid state NMR spectra of (a) untreated C6-AHL, (b) heat-treated C6-AHL 
with trehalose, (c) heat-treated trehalose, and (d) untreated trehalose ............................123
1 
CHAPTER 1 
ENGINEERED NANOPARTICLES TO ATTACK BACTERIA 
 
The seminal realization of the nanotechnology, and its potential to be manipulated at 
molecular and atomic scales developed over a half century ago.
1
 However, largely due to 
a lack of technical capability, a time of obtuse contemplation followed. During this initial 
lull in nano-based research, the 1950s and 60s saw a surge of attention in the 
development of antibiotics – the wonder bullet cited to stop all bacterial disease. 
However, this phenomenon was quickly tempered by a rapid emergence of antibiotic 
resistance (AR) among pathogens, often in the form of multi-drug resistance (MDR). AR 
continues to grow today, and at present, the future utility of traditional antibiotics remains 
questionable.  
 The surge in nanoresearch, coupled with dramatic increases in technical 
capabilities, has allowed the disparate fields of nanochemistry and antibiotics to come 
together. Traditionally, nanoparticles and nanomaterials have been developed as carriers 
to deliver anticancer and other forms of drugs to eukaryote cells. Given this foundation, 
the delivery of antibiotics using engineered nanoparticles has become an emerging and 
realistic area of research. Overcoming the problem of antibiotic resistance, however, 
requires a more in-depth understanding of interactions between the biology of 
2 
microorganisms and the physical chemistry of nanoparticles. This understanding is 
necessary in order to ultimately target bacteria, and overcome their immense arsenal of 
defenses. This review centers on fundamental, RAFT-based and timed-release surface 
chemistry, which is currently being developed for nanoparticle delivery of antibiotics to 
bacteria. We also integrate approaches being developed to enhance the detection and 
quantification of bacteria within biological systems. Concurrent with this chemistry is a 
necessary overview of certain bacterial processes, as these directly and indirectly interact 
with the chemistry of nanoparticles.  
 
1.1 NANOPARTICLES AS DRUG CARRIERS: A BRIEF HISTORICAL 
PERSPECTIVE 
 Credited for conceiving the idea of a “magic bullet” to selectively target toxic 
organisms in the body, Paul Ehrlich inspired many pioneers of the nanoparticle field. In 





 and eventually the first nanocapsules.
5
 Their ultimate goal 
was to achieve sustained drug release from nanocapsules in the blood after intravenous 
injection. 
 Since that time, nanoparticles have been used for pharmaceutical and medical 
applications, mainly for cancer treatment
6
 and enhancing the efficacy and targeting of 
cancer drugs.
7,8
 This has allowed for the use of lower concentrations of highly-toxic 
drugs in an effort to reduce side effects.
9
 More recently, and in conjunction with the 
important discovery that polyethylene glycol chains on nanoparticles prolong blood 
circulation and reduce liver uptake,
10
 studies have been conducted on the ability of 
3 
nanoparticles to cross the blood brain barrier, and target deep brain tumors or 
infections.
11-14
 The innovative research of the past 50 years has reinforced the roles of 
nanoparticles as drug delivery vehicles and has inspired the current diversity in 
nanoparticle research. Today, investigators focus their nanoparticle research on 
recognition, sensing, imaging, and delivery in biological systems with a broad range of 
core materials. 
 
1.2 THE ANTIBIOTIC DILEMMA: THE MODE OF DELIVERY COUNTS 
 Antibiotics are molecules produced by microorganisms to inhibit other 
microorganisms. Several major classes of antibiotics, based on their chemical structure 
and mechanisms of actions, are currently known. Since bacteria produce antibiotics, 
inherently they also possess mechanisms to resist their inhibitory actions, which can be 
passed on to nearby cells. Bacteria have also demonstrated resistance towards the 
naturally antimicrobial compounds used to construct NPs, such as silver and copper. This 
section addresses the molecular structure of antibiotics, and provides a basis for 
understanding their key activity sites on molecules, and how these relate to their 
inhibitory action(s). It sets a stage for why and how NPs can be used to enhance delivery 
and activities of antibiotics. 
 
Chemistry of antibiotics: structure and design 
 Selman Waksman coined the term ‘antibiotic’ to describe any small molecule 
made by a microbe intended to antagonize the growth of another microbe.
15
 Waksman, 
along with Fleming, Chain, Florey, and many others, was a pioneer of the ‘golden age’ of 
4 
antibiotics. Although we have been aware of the healing nature of moldy foods for 




 centuries that scientists began to 
understand that the provenance of antibiotics was related to the antagonism between two 
microorganisms. In 1928, British scientist Alexander Fleming witnessed the fungus 
Penicillium notatum produce a compound, that he named penicillin, which prevented the 
growth of the bacterium Staphylococcus aureus. By 1939, Florey and Chain manipulated 
P. notatum to produce large quantities of a stable form of penicillin.
16
 The cooperation of 
scientists from Great Britain and the United States resulted in clinical trials and the mass 
production of penicillin during the final, crucial years of World War II. Also during this 
period, Waksman and colleagues isolated several antibiotics from filamentous, soil-
dwelling bacteria of the genus Actinomycetes. 
 Since the groundbreaking work of the 1940s, nearly 25,000 natural, synthetic, and 
semisynthetic antimicrobials have been discovered. 20,000 of these are naturally 
occurring drugs produced by soil-dwelling fungi and bacteria.
17
 Although there is an 
excess of available bioactive and toxic compounds, less than 1% are clinically useful. 
There are two major classes of antibiotics: bactericidal and bacteriostatic. Bactericidal 
antibiotics, like the -lactam compounds penicillin and cephalosporin, kill bacteria. 
Bacteriostatic antibiotics, like tetracycline and its many derivatives, inhibit the 
proliferation of bacteria. Compounds that act on both Gram-positive and Gram-negative 
bacteria are classified as broad-spectrum antibiotics. Compounds that act on only a 
specific group of bacteria are narrow-spectrum antibiotics. The most studied and relied 
upon antibiotics have been repeatedly proven to be nontoxic to humans and highly-toxic 
5 
to pathogens. For the purpose of this review, we will briefly discuss the pharmacokinetic 
and pharmacodynamic properties of the major classes of antibiotics.  
 
Major classes of antibiotics and mechanisms of action 
 Pharmacokinetics describes the effects of the body on the actions of a drug. The 
pharmacokinetics of an antibiotic dictates its absorption, distribution, metabolism, and 
elimination by the body. Non-ionized molecules are more lipid soluble than ionized 
molecules and can readily diffuse across the cell membrane. Since ionized molecules are 
less able to penetrate the lipid membrane; their entry depends on the leakiness of the cell 
membrane, as related to electrical resistance. The transmembrane distribution of a weak 
electrolyte is influenced by its pKa and the pH gradient across the membrane, where pKa 
is the pH at which half of the compound is in its ionized form. Antibiotics rely on passive 
transport (paracellular transport or diffusion) or active transport (facilitated diffusion or 
drug transporters) to cross cellular barriers. Due to the presence of a carboxyl group 
(essentially a proton donor), -lactams are considered weak acids and do not readily cross 
the cell membrane (of mammalian or bacterial cells).
18
 
 To understand the pharmacokinetic transport of an antibiotic to a bacterial cell, it 
is important to briefly consider the fundamental structural differences between Gram-
negative and Gram-positive bacteria (Figure 1.1).  
 Pharmacodynamics refers to the study of the biochemical and physiological 
effects of drugs and their mechanism of action. In the case of antibiotics, the barriers 
inflicted by human anatomy, the chemical properties of the antibiotic, and the presence of 
multidrug transporters among the many types of cells along this pathway influence the 
6 
efficacy of antimicrobial therapy. The penetration of physical barriers by antibiotics is 
directly related to the octanol-water partition coefficient (Kow) of the antibiotic. 
Generally, hydrophobic drugs (with high Kows) become concentrated in the lipid 
membrane of cells, while hydrophilic drugs typically concentrate in aqueous areas such 
as the blood or cytosol. Additionally, the larger and more negatively charged an antibiotic 




 The extracellular concentration of an antibiotic directly affects the intracellular 
concentration in a concentration- and time-dependent fashion,
21-24
 depending on the drug 
and microorganism. An antibiotic intended to target an intracellular infection must cross 
the cell membrane and retain activity in the cytosol.
25
 The equilibrium of free and bound 
(to protein, stabilizing agent, serum, etc) antibiotics directly alters active transport, pH 
partitioning, and accumulation in the host, and therefore influences its ability to cross the 
cell membrane and target an intracellular infection.
26
 Additionally, the intracellular 
activity of antibiotics is largely influenced by the pH of the vacuoles and lysosomes in 
which it becomes localized, and the level of bacterial (i.e. growth rate, presence of 
persister cells, and small colony variants
27-29
) and cellular activity.
25
 Alternatively, the 
antibiotic oritavancin (i.e. a semi-synthetic glycopeptide) is unaffected by pH, but shows 





 To date, -lactam compounds are the most important broad-spectrum antibiotics 
and the most commonly prescribed. The most well-known examples of the fungal-
7 
derived drugs include penicillin and cephalosporin. Simply put, -lactams bind 
irreversibly to enzymes intended to catalyze the transpeptidation of the peptidoglycan 
layer of the bacterial cell wall. -lactams prevent proper reconstruction of a cell wall, 
eventually weakening and lysing the bacterial cell.
30-31
 
 More specifically, -lactams are a large class of drugs that primarily target the 
penicillin-binding proteins (PBPs) required for bacterial cell wall synthesis. This class is 
characterized by a highly reactive, four-membered carbonyl lactam ring containing 
azetidinone
32
 and includes penicillins, narrow- and extended-spectrum cephalosporins, 
monobactams and carbapenems.
33
 -lactams target peptidoglycan biosynthesis by 
blocking the insertion of glycan units into the cell wall to inhibit cell wall development 
and by blocking transpeptidation linking and maturation.
34
 Peptidoglycan, found in both 
Gram-negative and Gram-positive bacteria, is an integral part of the cell wall that is 
required by bacteria to maintain the structural integrity of the cell and to survive changes 
in environmental osmotic pressure.
35
 -lactams form a covalent complex with enzymes 
(the PBPs) that generate the mature peptidoglycan molecule. The -lactam antibiotic, 
containing a cyclic amide ring, mimics the D-alanyl-D-alanine region of the PBP, forms a 
covalent acyl-enzyme complex with the activated serine of the PBP that inhibits the 
peptide bond formation reaction catalyzed by PBPs, and is mistakenly incorporated into 
the cell wall.
30-31, 36
 This complex inhibits transpeptidation activity and weakens the 
integrity of the cell wall, eventually resulting in cell lysis.
36
 Specifically, the PBP 
inhibition occurs by penicilloylation of the active site, which blocks the hydrolysis of the 
bond created with the now open-ringed drug and disables the enzyme.
32, 37-38
 A review by 
Kohanski and colleauges additionally explores alternative targets of -lactam activity 
8 
such as cell division, autolysin activity, the SOS response, the TCA cycle, Fe-S cluster 
synthesis, ROS formation, and envelope and redox-responsive two-component systems.
32
  
 Although -lactam antibiotics are highly effective against susceptible bacteria, 
they are most useful against extracellular infections within the body. Intracellular 
pathogens, such as Listeria monocytogenes and Salmonella species, are protected from 
the immune system by phagocytes and are less accessible to these antibiotics. Reports 
show poor accumulation of -lactams in phagocytic and nonphagocytic cells, possibly 
due to the acidic conditions of the cytosol and the presence of multidrug efflux pumps in 
both human and bacterial cells.
39,40
 The free carboxylic group on -lactams is essential to 
activity, and makes them a weak acid. Due to the acidic nature of the cytosol of 
phagocytic and nonphagocyctic cells, -lactams cross the membrane very slowly, if at all. 
The efficacy of -lactams is dependent upon time of exposure above MIC, so slow 
penetration renders them less effective at targeting intracellular pathogens.
41
 
 Resistance to -lactams arises through mutations in PBPs,
42
 acquisition of new 
PBPs with lower affinity for the drug,
43
 production of -lactamases that inactivate the 
drug by hydrolyzing the -lactam ring,
33, 42, 44-45
 changes in cell wall porins that limit 





 provides an in-depth review of the characterization and 
epidemiology of plasmid and transposon mediated -lactamases. Information on -
lactamase inhibitors, compounds used concurrently with -lactam antibiotics to fight 
resistant bacteria, can be found in papers by Drawz & Bonomo and Therrien & 
Levesque.
33, 47
 A detailed overview of bacterial resistance to -lactam antibiotics was 





 Tetracyclines are another group of medically-relevant antibiotics. They are 
bacteriostatic against a broad spectrum of Gram-positive and Gram-negative bacteria, and 
several protozoans. Tetracyclines act through interrupting protein synthesis by inhibiting 
the aminoacyl-tRNA from binding to the 30S ribosomal subunit of bacterial RNA. The 
antibacterial activity of tetracyclines is derived from the linear fused tetracyclic nucleus 
of six-membered carbocyclic rings, and their strong chelating ability.
49
  
 The basic structure of the tetracycline group of antibiotics consists of a linear 
fused tetracyclic nucleus with a variety of constituents. These structural features confer 
antibacterial activity to the tetracyclines.
49-52
 Several structure-activity studies have 
demonstrated that the rings of tetracycline must contain six members and be purely 
carbocyclic to retain antibiotic activity.
49
 The review by Chopra
49
 has detailed the mode 
of action of tetracycline. Briefly, in Gram-negative bacteria, which have both an outer- 
and inner-membrane, tetracycline diffuses across the outer membrane through porin 
channels as a positively-charged metal complex. The metal ion-antibiotic complex 
accumulates in the periplasm where it dissociates, and the uncharged tetracycline diffuses 
through the lipid bilayer of the cytoplasmic (i.e. inner) membrane. At this point, 
tetracyclines bind to the small ribosomal subunit and prevent the association of 
aminoacyl-tRNA with the ribosome and inhibit protein synthesis. Tetracyclines are 
strong chelators and are likely to become chelated within the cytoplasm. Therefore, the 
complex that binds to the 16S rRNA likely contains magnesium. Association of 






 Aminoglycosides (AGAs) were one of the first discovered and clinically used 
antibiotics. Hence, they are also one of the most resisted by human pathogens. The 
structure of AGAs varies. In general, AGAs consist of an inositol derivative linked to an 
amino-sugar and a variety of free hydroxyl and amino groups, potentially containing 
further substituents. These free groups interact with the 30S subunit of ribosomal RNA 
and interfere with protein translation. More specifically, AGA binds three adenines 
present in the A-site of the 30S ribosomal subunit. Binding stabilizes the 30S subunit, 
which subsequently allows the noncognate tRNA to bind and initiate a misreading of the 
mRNA, followed by the synthesis of faulty proteins.
55
 It is unknown how the loss of 
translational fidelity leads to cell death,
56-57
 but it has been suggested that the use of 
faulty proteins in the inner membrane destabilizes the cell.
58-60
 Resistance against AGAs 
by bacteria is inferred by aminoglycosidic-modifying enzymes (acyltransferases, 
phosphotransferases, nucleotidyltransferases, methyltransferases), target modification by 
mutation, change of uptake and efflux, and membrane proteases. A recent review by 
Becker and Cooper
55
 goes into specific detail. 
 
Macrolides   
 The macrolides are a class of natural and semisynthetic bacteriostatic antibiotics 
that are often used to treat respiratory, skin, and soft tissue infections. Macrolides contain 
a large lactone ring (12-16 atoms) attached to sugars with glycosidic bonds and 
substituted by hydroxyl or alkyl groups. Macrolides are subdivided into four classes 
based on the number of atoms in the lactone ring (12, 14, 15, and 16-membered rings). 
11 
Although the precise mechanism is unknown, macrolides bind to the 23s rRNA portion of 
the 50S ribosomal subunit to block protein synthesis.
61
 Kannan & Mankin
62
 provide a 
review of the binding and action of macrolide antibiotics in various microorganisms. 
They explain that macrolides bind in the nascent polypeptide exit tunnel of the large 
ribosomal subunit close to the peptidyl transferase center (PTC). In this position, 
macrolides inhibit the movement of proteins out of the ribosome and prevent translation 
elongation.
61, 63-64
 The macrolide establishes hydrophobic interactions with the rRNA 
residues belonging to domains II and V of the 23S rRNA. Crystallographic evidence has 
demonstrated that the macrolactone is positioned flat against the wall of the ribosome 
with the side chains protruding up towards the PTC active site and down the tunnel 
towards the exit. Although highly conserved, the slight variation in rRNA sequences 
among bacteria contributes to the spectrum of activity of macrolide antibiotics and 
indicates that the binding sites and modes of action may be species-specific.
65
 A brief 
review by Gamerdinger & Deuerling
66
 summarizes that inhibition of protein translation 
in the nascent peptide exit tunnel may be regulated by small metabolites and may play an 
important global role in cellular physiology. The inhibitory action of macrolides on the 
bacterial ribosomal tunnel is selective. Kannan et al. found that macrolides allow 
selective synthesis of full-sized and truncated proteins in bacteria,
67
 an action that 
influences the cellular proteome and may enhance toxicity. 
 
Sulfonamides 
 Sulfonamides are a structurally-related group of broad spectrum, bacteriostatic, 
synthetic antibiotics used for systemic application. Originally known as sulfa drugs, 
12 
compounds of this class of drugs contain a 4-aminobenzene sulfonamide backbone that 
inhibits the growth and reproduction of bacteria by competing with p-aminobenzoic acid 
during folic acid synthesis.
68
 Sulfonamides are unique polar molecules with amphoteric 
properties. At pH 2-3, the amino nitrogen is protonated, while at pH 4.5-11, the amide 
nitrogen is deprotonated.
69
 Application of these drugs began in the early 1940s, but was 
quickly phased out due to frequent bacterial resistance. Because of widespread resistance, 
sulfonamides are rarely used alone. Currently, combination drugs containing both 
sulfonamides and diaminopyrimidines are used to treat both Gram-positive and Gram-
negative infections.  
 A brief review of the mechanisms of action and resistance of sulfonamides are 
presented by Skold
70
. Sulfonamides interrupt the essential folic acid synthesis pathway in 
bacteria by mimicking p-aminobenzoic acid (pABA) and inhibiting dihydropteroate 
synthase. Often used in combination with sulfonamides, diaminopyrimidine next targets 
dihydrofolate synthase (DHPS), an essential enzyme of the folic acid synthesis pathway. 
DHPS catalyzes the condensation of p-aminobenzoic acid and 7,8-dihydro-6-
hydroxymethlpterin-pyrophosphate (DHPPP) to form dihydropteroic acid (the second to 
last step in the folic acid synthesis pathway). At this point, the sulfonamide is bound to 
DHPS. Crystallography shows that the sulfonamide is sandwiched between the main 
chain of Arg 200 and the side chain of Lys 221 on one side and the side chain of Arg 63 
on the other of DHPS. The sulfonamide NH2 donates a hydrogen bond to the carbonyl of 
Ser 219 and one sulfonamide oxygen accepts a hydrogen bond from the guanidinium of 
Arg 63 of DHPS.
71
 The competitive inhibition of DHPS by sulfonamides halts the folic 
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acid synthesis pathway and inhibits the growth of bacteria by eventually starving the cell 
of folic acid. 
 Bacteria exhibit resistance to sulfonamides through point mutations that affect 
binding of the inhibitor or through the acquisition of drug-insensitive enzymes that 





 Lipopeptides are a class of drugs including both natural and semi-synthetic 
antibiotics that target bacterial cell wall synthesis in Gram-negative and Gram-positive 
species. Lipopeptides are used in a range of applications as antimicrobial, antitumor, 
immunosuppressant, and surfactant agents. The lipopeptides are a structurally diverse 
class of antibiotics that contain a short linear peptide or an oligopeptide of either net 
negative or positive charge. The peptide portion of the lipopeptide varies in length and 
amino acid composition, and is covalently attached to a fatty acid at the N-terminus of the 
lipid moiety. In general, lipopeptides target the bacterial cell membrane and are highly 
active against multi-drug resistant bacteria. Specifically, lipopeptides form pores in the 







, and cell death.
72-73
  
 Lipopeptides, such as the anionic amphomycin and daptomycin, bind directly to 
the bacterial cell membrane where they interact with the lipid bilayer via electrostatic and 
hydrophobic interactions to cause rapid depolarization of the bacterial membrane 
potential.
74-77
 Upon interaction with the membrane, the peptide adopts a three 
dimensional structure and becomes amphiphilic, with the positively-charged side 
14 
interacting directly with the lipid head groups. The formation of a secondary structure is 
essential for the interaction of amphiphilic molecules with the bacterial cell membrane.
78
  
 The anionic compound daptomycin is active against Gram-positive bacteria, and 
requires calcium to lock into an active conformation. The addition of calcium ions leads 
to oligomerization of daptomycin and induces the formation of micelle-like structures.
78-
79
 The lipid tails point inward and the calcium ions help hold the charged side chains of 
daptomycin from different monomers together. Calcium is weakly bound (i.e., the system 
requires 1000 times more calcium than daptomycin) so the micelle can readily dissociate 
at the cell membrane surface.
80
 The initial binding event between the daptomycin 
aggregate and the bacterial membrane may be with the membrane lipid phosphatidyl 
glycerol.
81
 Daptomycin binds strongly to phosphatidyl glycerol head groups in the 
bacterial cell membrane.
82
 The large aggregates alter the membrane shape, leading to 
membrane leakage and eventual cell death. The daptomycin aggregates may also interfere 
with membrane-associated processes such as cell wall synthesis, cell division, and 
energetics.
83





Glycopeptides and glycolipopeptides 
 The glycopeptides and glycolipopeptides are a class of natural and semi-synthetic 
drugs derived from actinobacteria that target peptidoglycan synthesis in Gram-positive 
bacterial cell walls. The glycopeptides and glycolipopeptides act by binding to 
peptidoglycan units at the D-alanyl-D-alanine dipeptide terminus to block 
transglycosylase and PBP activity.
84-85
 These compounds act as steric inhibitors of 
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peptidoglycan maturation and reduce the mechanical strength of the cell. Some semi-
synthetic glycopeptides have been shown to interact directly with transglycosylase.
86
 





1.3 DIRECT AND INDIRECT ANTIMICROBIAL PROPERTIES OF 
INORGANIC NANOPARTICLES 
 Unique physical-chemical properties of inorganic nanoparticles have been utilized 
for hundreds of years.  More recently, certain types of inorganic NPs have been found to 
exhibit strong antimicrobial properties. However, their applications as antimicrobial 
agents are limited by their apparent toxicity to other biological systems (e.g. human 
cells). This section examines major types of inorganic NPs, and discusses the chemistry 
of their toxic- and/or non-toxic properties and antimicrobial mechanisms of action. This 
section also provides an overview of the methods used to determine efficacy of inorganic 
nanoparticles (luminescent biosensors, generation of ROS, DNA damage, cell membrane 
integrity, electron microscopy, live/dead assays, Raman scattering, SDS-PAGE analysis 
of proteins, gene expression, etc.) in a bacterial system. Given the ability of bacteria to 
protect themselves from natural stresses and reach a ‘viable but nonculturable’ (VBNC) 
state, techniques alternative to traditional culturing are required to judge the antimicrobial 






 The antimicrobial nature of silver, and silver compounds, has been utilized for 
hundreds of years. The surge of antibiotics in the 1940s reduced the medicinal reliance on 
silver, but in recent years there has been a comeback in its uses for wound- and burn-
dressings in a number of forms, including silver nanoparticles. Silver nanoparticles, in 
addition to silver ions, metallic silver, silver nitrate, silver sulfadiazine, and silver zeolite, 




 The antimicrobial effect of silver nanoparticles has been seen in Gram-positive 
bacteria, Gram-negative bacteria, and yeast.
91-95
 Silver nanoparticles are effective at 
preventing growth of bacteria on surfaces of agar plates, but are comparatively less-
effective in liquid medium, due to aggregation of colloidal silver in the presence of high 
salts and other media components.
94, 96-97
 These studies suggest that the antimicrobial 
ability of silver nanoparticles is dependent upon surface oxidation (of the nanoparticle) 
and particle dispersion. The size and shape of silver nanoparticles also play a major role 
in their ability to interact with the bacterial surface and release silver ions (Ag
+
) into 
solution. Given their enhanced surface area, smaller, spherical nanoparticles (1-10 nm) 
are more effective at attaching to the surface of a cell membrane and disturbing 
permeability and respiration than larger nanoparticles.
96, 98-99
 Thus, reducing the size and 
increasing the surface area of nanoparticles provides a greater number of reactive groups, 
Ag
+
 in this case, and is believed to enhance nanoparticle toxicity.
100-102
 Small 
nanoparticles penetrate the bacterial cell membrane and interact with the thiol groups of 
protein, preventing expression of ribosomal subunit proteins, deactivating the enzymes 
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and cellular components essential to ATP production,
99




 The mechanism of action of silver nanoparticles is not entirely understood, but 
current research has demonstrated that silver ions affect essential cellular components 
(cell membrane integrity, respiration, and ATP production). To date, there have been very 
few observations reported for microbial resistance against silver. Originally discovered in 
Salmonella typhimurium,
103
 and then later in Pseudomonas aeruginosa, Candida 
albicans, and the environmental isolate Acinetobacter baumannii, silver resistance has 
been the result of both intrinsic and acquired genes.
104
 The distinction between silver 
sensitivity and silver resistance is difficult to determine, however, because silver resistant 
phenotypes are not consistent. Silver resistance may be incurred by plasmids, specialized 




 Medical devices and wound dressings impregnated with silver nanoparticles have 
made a large impact on reducing infection in hospital settings;
106
 however, the toxicity of 
these compounds on humans is not fully understood. Cytotoxicity of silver nanoparticles 
on mammalian cells has been observed in vitro, demonstrating that silver nanoparticles 
may enhance the generation of reactive oxygen species
100, 107
 and damage DNA.
108-109
 
The potential for extensive DNA and cell damage is a precursor for carcinogenesis.
110
 
Although the primary condition currently associated with silver is the cosmetic ailment 
known as argyria (irreversible bluish-gray discoloration of the skin), further research is 
required before relying on silver nanoparticles as an antimicrobial agent. A thorough 
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Titanium dioxide nanoparticles 
 Titanium dioxide (TiO2) is a naturally-occurring compound that has been used 
extensively in cosmetics, sunscreen, and food additives because of its highly refractive 
qualities. Additionally, TiO2 nanoparticles have been utilized for their antimicrobial 
properties. When photoactivated by UV or visible light, TiO2 catalyzes the cleavage of 
water into hydrogen and oxygen, and produces reactive oxygen species (ROS) in 
solution.
112
 Currently, TiO2 nanoparticles, which can be activated by weak UV light, are 
used in interior furnishings such as tiles and wallpaper in hospital rooms, air conditioning 
and purification units, wastewater/sewage purification systems, and pollution abatement 
strategies to reduce bacterial loadings.
113
 
 Several studies have been performed to determine the antimicrobial efficiency of 
TiO2 nanoparticles. After photoactivation, TiO2 nanoparticles were highly toxic to E. coli 
and P. aeruginosa.
114-117
 The degree of toxicity was directly related to the cell wall of the 
microorganism, as E.coli (Gram-negative) was more susceptible than S. aureus and E. 




 The mechanism of action responsible for killing microorganisms exposed to 
photoactivated TiO2 is only partially understood. It has been theorized that the ROS 
generated through photoactivation are responsible for the antimicrobial efficacy of 
TiO2.
119




 in addition to creating single stranded or double stranded breaks in 
DNA, rendering it unable to be replicated.
121-122
 The antimicrobial activity of ROS varies 
between environments and experiments; therefore the exact mechanism of action is not 
fully understood nor agreed upon.
123
 Macrophages of mammalian immune systems rely 
heavily upon ROS to eliminate pathogens from the body. Therefore, microorganisms are 
exposed to ROS often, and have inherent defense mechanisms in place for protection. For 
example, Salmonella typhimurium sequesters iron ions to protect their DNA from ROS, 
in addition to the expression of a Type III secretion system that prevents the host cell 







Additionally, Salmonella enterica possesses several antioxidant enzymes that detoxify 
ROS.
126,127
 The inherent nature of photocatalysis and the creation of ROS limit the 
antimicrobial efficacy of titanium dioxide nanoparticles to aerobically grown organisms 
in water, air, or on surfaces. 
 
Gold nanoparticles  
 Colloidal gold has been used by scientists and medical practitioners for well over 
a thousand years. In the present day, due to its exceptional ligand binding ability, 
spectroscopic detection, high contrast in electron microscopy, and general stability, gold 
nanoparticles are widely used in biological and chemical systems. Extensive reviews on 
the syntheses and applications of gold nanoparticles have been published.
128-130
 
 Gold nanoparticles are readily taken up by host immune cells, thus enhancing 
their ability to deliver drugs to intracellular microbial pathogens.
131
 The exceptional 
binding of gold nanoparticles allows higher concentrations of complexed drugs to be 
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delivered to an affected area without releasing high levels of free, toxic drugs into the 
broader system. Gold nanoparticles lack the inherent antimicrobial effects noted for silver 
and titanium dioxide nanoparticles, therefore the simple presence of gold nanoparticles in 
solution with antibiotics is not enough to enhance the efficacy of antibiotics.
132-133
 
However, antibiotics, when conjugated to gold nanoparticles confer an increased and 
more targeted local concentration (of antibiotics) and help destroy microorganisms more 
efficiently than antibiotics alone, while reducing levels of toxic drugs in the system. For 
example, conjugation of ampicillin, streptomycin, and kanamycin to gold nanoparticles 
decreased their minimum inhibitory concentrations (MIC) to the bacteria Escherichia 
coli, Staphylococcus aureus, and Micrococcus luteus. In addition to enhancing the 
efficacy of these drugs, conjugating the antibiotics to gold nanoparticles also made these 
drugs more stable and heat tolerant.
134
 
 Conjugating antibodies to gold nanoparticles can allow for the targeting of 
specific microorganisms. Pissuwan et al. demonstrated that when antibodies were 
conjugated to gold nanoparticles, they selectively targeted and destroyed the parasitic 
protozoan Toxoplasma gondii after plasmonic heating.
135
 The in vitro experiment with 
antibody-conjugated gold nanoparticles killed approximately 80% of the parasite, 
whereas the antibody or gold nanoparticles alone did not kill a significant number of 
protozoa. Norman and colleagues used a similar approach to target the a multi-drug 
resistant strain of Pseudomonas aeruginosa.
136
 In their experiment, near-infrared 
irradiation was used to photothermally heat gold nanoparticles attached to P. aeruginosa, 
resulting in membrane disruption and 78% cell death. Additionally, vancomycin 
conjugated gold nanoparticles demonstrated activity against vancomycin-resistant 
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 Carbon nanotubes are single-wall (SWNT) or multiwall (MWNT) cylinders of 
graphene, valued for their unique size- and structure-dependent properties.
138
 Due to their 
strength and thermal and electrical conductivity, carbon nanotubes have a wide range of 
commercial applications. The synthesis and use of commercial carbon nanotubes has 
been thoroughly reviewed.
139-144
 Recently, the biological toxicity of carbon nanotubes has 
become a pressing issue as humans and the environment come into more frequent contact 
with the nanomaterials.
145-148
 Studies have defined the major mechanisms of toxicity to 
eukaryote cells to be oxidative stress, agglomeration, physical interactions, nutrient 
sequestering, shading effects, and metal catalyst residues.
149-156
 The potential for stress to 
humans and the environment indicates that other living organisms, such as bacteria and 
fungi may also be susceptible to carbon nanotubes. Currently, the exact mechanism of 
toxicity of SWNT towards bacteria is unknown; however, several studies have confirmed 
that membrane damage is a common result of SWNT treatment. The role of oxidative 
stress is still debated.
157
 
 One of the antibacterial first studies, conducted in 2007, showed that direct 
contact of carbon nanotubes with E. coli outer membranes caused irrecoverable damage 
and cellular lysis.
158
 Since then, multiple reports have confirmed that SWNT induce 
membrane damage and oxidative stress. A major challenge in using carbon nanotubes as 




 Modified SWNT have also demonstrated exceptional antibacterial activity. 
Vecitis and colleagues showed a significant loss in E. coli viability due to both membrane 
damage and oxidative stress with an increasing fraction of metallic SWNT.
162
 They 
suggest that the electronic structure of SWNT contributed to oxidative stress, while the 
physical structure damaged cell membranes. The difficulty in utilizing SWNT lies in their 
ability to nonspecifically damage many cells. However, functionalized SWNT have 
demonstrated lower toxicity to human cells than pure SWNT,
163-166
 while maintaining 
antibacterial activity. To this point, a recent study has shown that surface functionalized 
SWNT have enhanced functionality against microbes (as demonstrated by loss of cell 
wall integrity) with decreased cytotoxicity of human cells.
167
 The study showed that 
aggregation and dispersity of the SWNT were the major contributors to toxicity. 
Similarly, SWNT/PLGA composites have been shown to possess antimicrobial activity 
against E. coli and Staphylococcus epidermidis upon contact.
168
 Contact-driven toxicity 
may be related to the ability of the tube ends to puncture cell membranes, as short SWNT 
had a high density of uncapped tube ends and were found to be more toxic than longer or 
capped SWNT. The role of SWNT/PLGA composites is significant in the development of 
films for biomedical implants that do not promote bacterial growth. The ability of SWNT 
to inhibit biofilm growth, which is often seen on biomedical implants, has been 
demonstrated in both Gram-negative
169




Iron oxide nanoparticles 
 Iron oxide nanoparticles with a diameter size of 50-100 nm were first applied in 
magnetic resonance imaging more than 20 years ago.
171
 Magnetic nanoparticles with a 
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diameter of 10 nm were used in cancer therapy due to the hyperthermia effect.
172
 For 
drug delivery applications, magnetic nanoparticles have been utilized to carry 
doxorubicin, human serum albumin, and cottonseed oil to for cancer treatment.
173
 In 
addition, surface functionalization was conducted on magnetic nanoparticles with ligands 
and polymers to load drugs.
174-175
 Recently, magnetic SiO2 nanoparticles were used to kill 
pathogenic bacteria.
176
 As drug delivery vehicles, magnetic nanoparticles possess the 
unique advantage of guiding the nanoparticles to a desired location and keeping them 
localized at the site using an external magnet. 
 
Porous nanoparticles 
 The future of nanomedicine and drug delivery rests upon the ability of 
nanoparticles to complex a high concentration of drugs, release those drugs in a 
controlled and timely manner, control breakdown of the drug-nanoparticle matrix, have 
easily manipulated surfaces, and be detectable in vivo.
177
 Porous nanoparticles, such as 
silicon, iron (III) carboxylate, and manganese oxide, are ideal carriers for drugs having 
the previously listed capabilities.
177-179
 Silica nanoparticles have been widely applied as 
carriers for delivery of enzymes, antibiotics, and DNA.
180
 The biocompatibility of silica 
nanoparticles makes them an especially ideal carrier for applications associated with the 
human body. As an important class of silica materials, mesoporous silicas have attracted 
huge interest since their initial synthesis by Mobil Corporation in 1992.
181
 Mesoporous 
silicas have been widely utilized in the fields of catalysis and biomedicine
182-183
 because 
of their uniquely large surface area, controllable particle size and pore size, uniform pore 
structure, and easy surface functionalization. Although not inherently antimicrobial, these 
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nanoparticles have the potential to be designed to carry antibiotics to multidrug resistant 
infections. Currently, researchers are focusing on utilizing porous nanoparticles to deliver 
anticancer drugs into tumors with incredible accuracy
184-185
. Given the scope of the field 
of porous nanoparticles and drug delivery, further details will not be discussed here. 
 
Methods to determine efficacy of inorganic nanoparticles on bacteria 
 Given the ability of bacteria to protect themselves from natural stresses and reach 
a ‘viable but nonculturable’ state, techniques alternative to traditional culturing are 
required to judge the antimicrobial properties of inorganic nanoparticles. Bacterial cell 
culture techniques are frequently used in conjunction with other methods, such as 
luminescent biosensors, detection of reactive oxygen species, cell membrane integrity 
determination, and electron microscopy.  
 For example, the toxicity of silver nanoparticles on the growth rate of E. coli is 
often determined by UV spectroscopy (OD 600 nm) of bacterial cultures.
97
 Many other 
studies rely on traditional agar plates to count colony forming units during or after 
nanoparticle exposure. As an alternative and additive to these methods, bioluminescent 
bacteria such as Vibrio fischeri and genetically modified E. coli have been used in 
nanoparticle ecotoxicological studies. The V. fischeri bioluminescent “Flash Assay” is 
useful for screening highly turbid nanomaterials that would otherwise confound UV 
spectroscopy measurements.
186-189
 In addition to bacterial biosensors that indicate the 
overall toxicity of inorganic nanoparticles, bacterial biosensors have also been developed 
to detect the presence of inorganic nanoparticles. Blinova and colleagues presented a 
study using zinc and copper sensitive strains of bioluminescent E. coli. In this study, the 
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bioluminescence of the genetically modified E. coli increased proportionally with the 
increase in available zinc or copper.
190
 As an alternative to biosensors, the physical 
appearance of bacteria during nanoparticle exposure has also been used to determine 
toxicity.  
 Using electron microscopy, the membrane organization of bacterial cells can be 
visualized to determine if the nanoparticle treatment induced cellular lysis or cell wall or 
cell membrane damage.
97, 136, 191
 Less powerful microscopic techniques are also used to 
determine cell viability after nanoparticle exposure. Bacterial membrane integrity can be 
assayed with a fluorescent LIVE/DEAD stain (Syto9 and propidium iodide), and 
visualized via confocal scanning laser microscopy.
136, 183, 192
 In this assay, cells with 
intact membranes take up Syto9, while cells with disrupted membranes (and considered 
dead) are stained with propidium iodide. Fluorescence stains can also be utilized to detect 
the burst of free radicals and reactive oxygen species from bacteria during nanoparticle-
induced death. The oxidation of 2’, 7’-dichlorofluorescin-diacetate (DCFH-DA) can be 
used to quantitatively determine the formation of ROS by bacteria under a 
microscope.
193-195
 These alternative techniques to growth studies are important in their 
ability to determine cell viability without relying on cell culture techniques. 
 
1.4 LINKING ANTIBIOTICS TO INORGANIC NANOPARTICLES: 
CHALLENGES IN SURFACE CHEMISTRY DESIGN 
 The application of nanoparticles as drug delivery vehicles has attracted great 
attention in past decades. Nanoparticles possess unique properties, such as mono-
distribution of nanoparticle size, and thermal and magnetic properties.
196
 In addition, 
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owing to their unique physicochemical properties when compared to larger particles, 
provides the potential for nanoparticles to penetrate and reach areas of bio-membrane 
systems where dissolved molecules reach less-effectively. In the present section, we will 
explore how nanoparticle-based drug delivery vehicles can improve the solubility, 





 Surface functionalization of nanoparticles is of great interest because of their 
potential applications in chemosensors, coatings, organic light-emitting devices (OLEDs) 
and biomedical engineering.
198
 In the biomedical field, surface functionalization plays a 
critical role in tailoring the properties of nanoparticles for enhanced binding capabilities 
for therapeutic delivery,
199








 Positive charges, negative charges, and zwitterionic moieties have been 
functionalized onto nanoparticle surfaces. Cationic compounds have been considered 
important candidates for antimicrobial agents throughout the past twenty years. Among 
them, quaternary ammonium (QA)
201
 and phosphonium-based compounds
202-203
 are two 
main forms of these agents. QA compounds are the most important and commonly-used 
cationic agents used to kill bacteria. Dong and coworkers modified magnetic 
nanoparticles with poly(quaternary ammonium) (PQA) to kill E. coli, which retained a 
100% biocidal efficiency over eight-cycles of usage of the nanoparticles.
204
 Tiller and 
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coworkers functionalized glass slides with poly(4-vinyl-N-alkylpyridinium bromide) to 
kill airborne bacteria on contact.
205
 The antimicrobial properties of QA compounds are 
likely ascribed to their interactions with bacterial cell membranes, which subsequently 
results in disruption of the membranes.
206-208
 Carmona-Ribeiro reviewed the specific 
functions of cationic materials when interacting with bacterial cell membranes and 
summarized several general steps for disruption of cell membranes.
209
 We refer interested 
readers to the literature for detailed information in this field.  
 QA compounds can also be used as drug delivery vehicles to load and release 
antibiotics. Lee et al. have demonstrated that MSN can be functionalized with surface 
positive charges to deliver an anionic anti-inflammatory drug, sulfasalazine, with 
controllable loading, and release by changing pH value.
210
 The positive charge surface 
was synthesized by a condensation reaction between trimethylammonium (TA)-silane 
and tetraethoxysilane (TEOS) of MSN. Sulfasalazine was loaded into the nanoparticle 
and remained in the framework of MSN under acidic conditions. It was then released by 
electrostatic repulsion from the gradually-formed negative surface charges that developed 
under neutral conditions (Figure 1.2).  
 Surface functionalization with negatively-charged compounds has also been 
widely investigated for antimicrobial or other biomedical applications. It is reported that 
positively charged nanoparticles demonstrate higher internalization in eukaryote cells, 
while negatively charged nanoparticles are taken up by diffusion.
211
 Surface attached 
anionic compounds can be employed as drug delivery vehicles to kill bacteria. Riffle and 
coworkers modified Fe3O4 nanoparticles with block copolymers PEO-b-PAA.
212
 The 
unattached segments of PAA provide thousands of anionic carboxylates which was used 
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to conjugate cationic aminoglycoside antibiotics via ionic complexation for therapeutic 
applications. The delivery vehicles can also be used to deliver moieties such as metal 
ions. Anionic poly(3-sulfopropyl- methacrylate) brushes were prepared on Si/SiO2 
surfaces and employed to complex silver ions inside the brushes.
213
 The surface-attached 
silver-containing brushes inhibited the growth of both Gram-negative and Gram-positive 
bacteria. 
 Zwitterionic materials (also called inner salts) with one pair or multiple pairs of 
positive and negative charges in their structures have also been anchored on a variety of 
surfaces. Surface attached zwitterionic materials were shown to be resistant to bacterial 
adhesion and biofilm formation.
214
 However, most of the applications of these surface 
attached zwitterionic moieties are still used in the antifouling field. These anchored 
zwitterionic materials are found to highly-resist to protein adsorption. The two main 
zwitterionic materials are based on sulfobetaine (SB) and carboxybetaine (CB). Thus, SB 
based sulfobetaine methacrylate and CB based carboxybetaine methacrylate materials 
have been widely investigated as antifouling materials.
214-223
  
 Surface functionalization using different charge moieties can be characterized by 
a zeta potential test.
224
 This test reveals the surface electrical potential, which can be used 
to analyze their stability in solution. Generally, nanoparticles have been demonstrated to 
exhibit a stable dispersion in solution when the zeta potential is above ±30 mV. It is well 
known that the surface charge can inhibit aggregation of nanoparticles, thus surface 
modifications that introduce appropriate amounts of charges are an effective method to 
store nanoparticle suspensions.  
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Ligands and polymers 
 Relatively small molecules represent an operational class of materials that have 
been widely used to modify the surfaces of nanoparticles. They provide several 
advantages, such as low molecular weights, easy coordination onto nanoparticles, and 
easy processing conditions. Compared to macromolecules, the relatively smaller size of 
these molecules makes surface functionalizations with multiple ligands much easier. In 
the last section, charged small-molecule compounds were reviewed for surface 
modification. Thus, this section will only cover non-charged small-molecule ligands.  
 A wide range of small molecule ligands (SMLs) have been coated onto 
nanoparticles for applications in biosensing, diagnosis, and drug delivery.
225-230
 Those 
ligands can alter the nanoparticle’s stability, hydrophobic/hydrophilic properties, zeta 
potential, cytotoxicity, and the interactions with cells.
231-233
 
 Small molecules provide a repulsive layer on particle surfaces, which can enhance 
the stability of nanoparticles in suspension and minimize nanoparticle aggregations. Two 
factors should be considered while choosing SMLs for nanoparticle stabilization: 1) the 
substrate particles, and 2) the dispersion solvent. Generally, silane SMLs are used to 
modify SiO2 nanoparticles, thio SMLs are suitable to coat Au-nanoparticles and 
phosphate-based SMLs can be employed to functionalize iron oxide and TiO2 
nanoparticles. De and coworkers have summarized the surface functionalization of a 
variety of nanoparticles with corresponding SMLs.
234
 In all of the nanoparticle surface 
functionalizations, SMLs were bound to surfaces via chemical absorption or physical 
absorption (hydrophobic/ hydrophilic interactions). The dispersion solvents consisted of 
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organic solvents and water. Choosing appropriate solvents with a polarity close to that of 
the dispersion solvent is a necessary step while modifying particles.  
 Ligand exchange is a significant method to enhance the stability of nanoparticles 
in certain solvents. In this process, strongly bound ligands are typically used to replace 
weakly bound molecules to pursue firm surface attachment. For example, oleic acid, a 
significant and commonly used ligand for stabilizing metal oxide nanoparticles, is a 
weakly bound molecule and is generally exchanged with phosphate- and silane-based 
ligands
235-237
 for firmer attachment. Schadler et al. reported using a phosphate-azide 
ligand to replace oleic acid on TiO2 and ITO surfaces,
238
 followed by further 
functionalization via “click chemistry” on the new ligand.  
 Generally, oleic acid or oleylamine are added to stabilize magnetic iron oxide 
nanoparticles in the preparation process. However, it limits the surface functionalization 
of particles and reduces the dispersion of the particles in hydrophilic media. Thus, ligand 
exchange is necessary for further applications of magnetic iron oxide nanoparticles. 
Bronstein and co-workers used N-(6-aminohexyl)-aminopropyltrimethoxysilane to 
replace oleic acid on iron oxide nanoparticles to stabilize the particles.
239
 Binder and co-
workers employed 1,2-diols bearing -azido or -bromo ligands to replace octylamine or 
oleic acid on -Fe2O3 nanoparticles followed by post-functionalization of the new ligand 
to obtain fluorescent properties.
240
 Sun and coworkers replaced oleylamine via ligand 
exchange to convert the nanoparticles from hydrophobic to hydrophilic for develop a 
stable dispersion in an aqueous environment.
241
 Hatton et al. replaced oleic acid with 





 Ligand exchange is also an important tool for surface modification of 
nanocrystals. Murray and co-workers used nitrosonium tetrafluoroborate to replace oleic 
acid or oleylamine on nanocrystals to stabilize the nanocrystals in various hydrophilic 
solvents and made the ligand exchange reversible.
243
 Talapin et al. used metal 
chalcogenide complexes to exchange ligands on nanocrystals, an exchange that resulted 
in a hydrophilic property.
244-245
 In addition, surface functionalization of nanocrystals via 




 Surface coating of polymers on particles impart new properties to the surfaces.
253-
254
 The coatings can be used to further manipulate the nanoparticle’s stability in 
suspensions, the hydrophobic and hydrophilic properties, cytotoxicity, biocompatibility, 
and even interactions with cells. It also provides an additional platform to control the 
antibiotic loading and release on nanoparticles in drug delivery systems. In this section, a 
variety of common surface-modified polymers that were developed in recent years will 
be reviewed based on the class of the polymer.  
 Polymers containing cationic moieties have been coated onto surfaces to kill 
bacteria.
255-257
 The mechanism of the antimicrobial effect of cationic polymers has been 
discussed in the previous section. Generally, this class of polymer processes alkyl 
pyridinium or quaternary ammonium groups.
258
 Many quaternary ammonium based 
cationic polymers are prepared based on 2-dimethylaminoethyl methacrylate 
(DMAEMA).
258-261





PDMAEMA brushes determine the effect of killing bacteria. The higher charge densities 




based QA compounds are prepared via the quaternization with alkyl halide, but viologen-
quaternized PDMAEMA demonstrated significantly increased antimicrobial activity 
compared to alkyl halide-quaternized QA compounds due to the enhanced cationic 
charged densities.
262
 Other quaternary ammonium based cationic polymer materials have 
been developed in recent years. As a renewable material, rosin based polymers containing 
multiple quaternary ammonium compounds have been developed to kill bacteria.
257, 263-264
 
Alkyl pyridinium based polymers are usually prepared based on 4-vinyl pyridine. 
Quaternized poly (vinylpyridine) brushes were coated on glass surfaces to kill Gram-









 Klibanov and coworkers have developed surface-immobilized N-hexyl-
poly(vinylpyridine), N-Hexyl,N-methyl-polyethyleneimine (PEI), N-dodecyl,N-methyl-
PEI permanently microbicidal materials.
266
 
 Poly(ethylene glycol) (PEG), a hydrophilic polymer, has been used to enhance the 
water solubility of materials, and as such, is a significant polymeric material that is 
widely-used in bioapplications owing to its unique properties of exceptional 
biocompatibility and non-toxicity.
267
 Surface-coating with PEG can act as antifouling 
materials, as it prevents protein absorption and minimizes cell attachment.
267-268
 Surface-
anchored PEGs have also been reported to prevent protein absorption, enhancing 




 Temperature-responsive poly(N-isopropylacrylamide) (pNIPAAm) is a unique 
polymer that alters its conformation predictably in response to different temperature 
ranges. Surface anchored PNIPAAm shrinks and generates pores on nanoparticles 
33 
allowing entrapped antibiotics and biomolecules to be released when the temperature is 
raised above the low critical solution temperature (LCST). The polymer swells and closes 
the surface pores to inhibit release when the temperature is below the LCST. These 
properties can be used to control drug release by adjusting the temperature.
276-277
 





 Yavuz et al.
276
 reported the controlled drug 
release of pNIPAAm-grafted Au-nanocage by adjusting the near-infrared laser to 
generate heat. The monomers NIPAAm and acrylic amide were polymerized by atom-
transfer radical polymerization (ATRP) using a disulfide initiator (Figure 1.3). 
PDMAEMA is also a significant temperature-responsive polymer with a LCST around 45 
°C in aqueous solutions while at pH 8.5. However, the PDMAEMA polymer is also pH-
responsive due to the presence of multiple amino groups in its structures. Thus, the LCST 




 Since pH responsive polymers usually contain ionizable groups in their structures, 
they can be protonated and deprotonated under different pH conditions. Generally, there 
are two classes of pH responsive polymers, namely acidic- and basic-polyelectrolyte (i.e., 
polyacids and polybases, respectively). Representatives of polyacids are poly(acrylic 
acid) (PAA) and poly(methacrylic acid) (PMAA). Both contain multiple carboxylic acids, 
which can be used to chemically- or physically-bind small molecules. Using this 
approach, they have been coated on nanoparticles to kill bacteria as antibiotic delivery 
materials.
176, 212, 284-285
 The representative of polybase is PDMAEMA. The main 
applications of PDMADEMA are preparing antimicrobial materials via quaternization. 
34 
However, it has also been immobilized on various surfaces for biomedical applications 




Polymer preparation by controlled radical polymerization 
 Generally, surface functionalization of nanoparticles with polymers has been 
achieved using two methods, namely, “grafting from” and “grafting to” techniques.
288
 
The “grafting from” technique provides a higher surface modification density than 
“grafting to” strategy due to the gradually increasing steric hindrance from already-
grafted polymer chains that occurs in the “grafting to” technique. Controlled/Living 
radical polymerization (C/LRP) has been employed in the “grafting from” technique due 
to its powerful application in the synthesis of well-defined and advanced structure 
polymers, such as block copolymers, branch polymers, and star-shape polymers. Among 





 and reversible addition-fragmentation chain 
transfer polymerization (RAFT)
292
 have been excessively applied in the complex polymer 
structure synthesis.
293-298
 Surface functionalization of nanoparticles via controlled radical 
polymerization generates controlled chain length and polydispersity of polymers on 
surfaces. 
 The first report, to our knowledge, of surface functionalization using ATRP was 
in 1997 by Wirth and co-workers.
299
 Acrylamide was polymerized via ATRP on benzyl 
chloride-attached silica surfaces. Then, Matyjaszewski and co-workers significantly 
expanded grafting polymers from surfaces via ATRP.
291, 300-301
 The first report of surface 




Since the invention of RAFT in 1998, it was first used to modify surfaces by Tsuji et al. 
in 2001.
303
 They prepared the RAFT agent in-situ by conversion of a surface-supported 
ATRP initiator followed by surface-initiated RAFT polymerization of styrene. Brittain 
and co-workers employed azoundecylchlorosilane as an anchor-initiator to commence 
RAFT polymerization on silica particles.
304
 Brittain et al. also employed “click” reaction 
to anchor RAFT agents on silica particles to mediate the polymerization of styrene and 
methyl methacrylate.
305
 Benicewicz and colleagues employed a RAFT agent 4-
cyanopentanoic acid dithiobenzoate (CPDB) to prepare a wide range of polymers from 





 Thus, CRP methods have been tremendously important techniques for the “grafting 
from” method to prepare polymer grafted nanoparticles.
306-309
  
 CRP has also been widely applied in preparing a variety of free polymers, which 
are further used in “grafting to” strategies. Both “grafting to” and “grafting from” 
strategies have been demonstrated as effective methods to graft polymer brushes on 







 Normally, NMP require high reaction temperatures and ATRP generates residue 
copper or other metal after polymerization, which is extremely difficult to be completely 
removed. Thus, both of NMP and ATRP have not been widely applied on nanoparticle 
surfaces for biomedical applications. RAFT, generally employing mild reaction 
conditions without residue metal issues after polymerization, is adaptable to a variety of 
functional monomers.
284, 303, 306, 314-315
 Due to the advantage of the RAFT technique, it has 











Controlling specificity in targeting bacterial cells  
 In recent years, and with increasing effort to understand the human microbiome 
(i.e. the bacterial communities inhabiting humans), it is now realized that the majority of 
bacteria inhabiting humans are non-pathogenic (i.e. commensal), and may even play 
essential roles in health.
320
 Most antibiotics, however, target general bacterial processes 
(e.g. cell wall formation, protein translation, DNA replication, etc. See Section 2), so 
even relatively ‘narrow-spectrum’ antibiotics have lethal effects on many commensal 
forms; which in turn, are thought to negatively affect human health. Therefore, a major 
challenge in the future development of antibiotics will be in designing approaches that 
target only the pathogenic (i.e. infection-causing) forms, while leaving the majority of 
commensal bacteria intact. 
 One approach for targeting specific bacteria has been the use of antibodies. 
Antibodies are produced by the immune response of a mouse, rabbit, or rat,
321
 and can be 
raised against specific proteins (antigens) located on the surface of the bacterium. The 
antibody, after purification, is typically conjugated to a fluorophore for detection, and 
then used to identify (via its fluorescence) specific bacteria with the antigen signature 
amongst a plethora of other species/strains in a complex mixture.  
 Nanoparticles, when coupled with antibodies, have been used as carrier vehicles 
for highly-sensitive biodetection of specific bacterial pathogens.
322-324
 NP-based 
approaches allow single-cell detection because a single NP contains many fluorophore 
molecules. Efficient and sensitive detection of bacteria is necessary for maintaining food 
quality, and in environmental and biomedical applications. Traditional detection 
techniques, such as viable colony counting
325
 and polymerase chain reaction (PCR) to 
37 
detect pathogen genes, impose a high cost and are time expensive. Comparably, 
nanoparticles provide an excellent platform for sensitive and efficient detection because 
nanoparticle surfaces can be functionalized and quickly modified with specific antibodies 
to recognize biomarkers on bacteria.  
 The relatively large size (ca. 150 kDa) of many antibodies limits their ability to 
disperse under many biological conditions, especially when conjugated to nanoparticles. 
Antibodies are Y-shaped glycoprotein molecules, and consist of both a framework (FR) 
and hypervariable (HV) region. The tail of the HV region provides the antibody with 
specificity for the binding antigen (i.e. the binding domain). A small section of this tail 
(containing the binding domain) has been used to facilitate the development of 13 kDa 
single-domain antibodies (sdAbs) that can be conjugated to quantum dots (QD) (<12 nm 
dia.). The sdAbs can be conjugated to QDs in a highly-oriented manner to enhance 
binding efficiency and be used as ultra-small diagnostic nanoprobes.
324, 326-327
 In general, 
antibody conjugated-nanoparticles have been used for highly sensitive detection of 
specific species within a complex mixture of bacteria.
322, 328-331
  
 Antibody conjugated-nanoparticles can also be designed as multifunctional 
platforms for targeted bacterial detection and destruction. When nanoparticles are 
equipped with magnetic properties (as discussed above), then conjugated with antibodies, 
they can be used for detection and/or separation of specific bacteria from a mixture of 
species.
323, 329, 332
 For example, antibody conjugated-magnetic nanoparticles, can separate 
the bacteria E. coli and Salmonella typhimurium,
333





 cells/mL. Magnetic nanoparticles have also been applied as sensors to enhance 
interactions between vancomycin coatings on nanoparticles and D-alanyl-D-alanine in 
38 
bacterial cells, with a corresponding detection limit of 10
3
 cells/mL. The antimicrobial 
enzyme lysostaphin was adsorbed on the surface of antibody conjugated-nanoparticles 
specific to the bacterium Staphylococcus aureus.
334
 Lysostaphin hydrolyzes the 
peptidoglycan linkages in the cell wall to lyse and kill the bacterium. 
 The unique size effect and emerging surface functionalization toolboxes make 
nanoparticles an excellent platform to efficiently and sensitively detect bacteria. As 
discussed earlier in this review (see Section 4.1), the surfaces of nanoparticles can be 
engineered with RAFTs at finely-controlled densities to tailor the accessibility of the 
conjugated moieties on the RAFTs. In this way, several different antibiotics can 
potentially be delivered by a single nanoparticle. This approach offers an exciting 
potential to increase the specificity of an antibiotic attack and to reduce destruction of 
helpful bacteria by antibiotics.  
 Finally, in order for nanoparticle-based approaches to operate efficiently, the 
nanoparticle-carrier must either penetrate the bacterial cell (as discussed below), or 
release its cargo at the cell surface. Approaches for the controlled release of conjugated 
molecules from nanoparticles has been developed using both pH-sensitive and infrared-
sensitive ligands.  
 
Entry of nanoparticles into the cell 
 Certain antibiotics, owing to their mechanism of action, require entry into the 
cytoplasm in order to kill or inhibit bacterial cells. Together, the cell membrane(s) and 
cell wall provide a protective barrier that restricts the movement of molecules and ions 




mentioned earlier, the outer membrane (OM) forms the outermost boundary with the 
extracellular environment of Gram-negative bacteria, while the cell wall accomplishes 
this in Gram-positive species (Figure 1.1). The OM and inner (plasma) membranes (IM) 
selectively allow smaller molecules ( <600 Da) to diffuse through the lipid bilayer while 
preventing macromolecules larger than 1 kDa
336
 from permeating the membrane without 
active transport.  
 Many studies have shown that the interaction of some metallic nanoparticles with 
bacteria results in cell lysis (and death).
188, 337-338
 In these studies, the nanoparticles used 
were relatively toxic and included ZnO, CuO, Ag, TiO2, and Al2O3. In some cases, 
nanoparticles were observed within lysed cells, suggesting that the nanoparticles were 
taken up by cells and cell death occurred either during or shortly after uptake.  
 It is now realized, however, that bacteria may also take up very small particles 
into their cellular cytoplasm, without apparent lethal effects. For example, quantum dots 
(<10 nm diameter) were shown to be taken up via a purine-dependent mechanism.
339
 
Also, 10 nm diameter gold colloids have been shown to enter viable cells during the 
uptake of large proteins.
340
 Although examples exist, particle uptake by bacteria is 
contrary to our current understanding, and is not well understood. Very few studies have 
noted either direct or indirect uptake.  
 In order for non-lethal particle uptake to occur, the process will likely require 
active transport, and the ability of the bacterium to hydrolyze a small portion of the cell 
wall, and then reform the wall without significant loss of intracellular contents. The 
interior of a bacterial cell, however, has a high turgor pressure relative to the immediate 
outside environment. Successful entry into a bacterium without cell death presupposes 
40 
that the particle can cross through the cell membrane(s) and cell wall without lysis and 
significant loss of intracellular contents. How this might occur is currently unknown. 
 Some insight can be gained from the examination of the uptake of 
macromolecules into larger eukaryote cells.
341-342
 This process, called endocytosis, 
utilizes membrane vesicles to shuttle extracellular materials into the cell. There are two 
methods of endocytosis, classified as phagocytosis or pinocytosis.
343-344
 Pinocytosis 
includes macropinocytosis, clathrin-mediated endocytosis, and caveolae-mediated 
endocytosis, as shown in the Figure 1.4 and Table 1.1.
345-346
 These endocytosis pathways 
differ from each in the nature of the internalized materials, the size of vesicles, the type of 
cells, and the kinetics of the uptake process.
345
 However, endocytotic-like uptake by 
bacteria has only been shown in one case, 
340
 and is not well understood at present.  





the cytosol by endocytosis in eukaryote cells. Without the nanoparticle carrier, these 
molecules would not be able to diffuse through the lipid bilayer.  
 The interaction between nanoparticles and the cell membrane can be influenced 
by the size, shape, surface charges, and surface functional groups of nanoparticles. For 
example, Chithrani et al. reported that 50-nm Au nanoparticles were more efficiently 





 were reported to be internalized 500% more than rod-shape 
nanoparticles in eukaryotes. The nanoparticles size and shape have been reported to 
influence the binding of receptors on the cell membrane.
349
 The surface coating on 
nanoparticles can be designed to inhibit protein absorption and minimize nonspecific 
interactions with cell membranes. For example, neutral ligands such as poly(ethylene 
41 
glycol) (PEG) and zwitterions have been used to reduce inefficient targeting and potential 
agglomeration of nanoparticles at the cell surface.
350-352
 Nanoparticles with surface 
negative charge moieties have been reported to have poor interactions with the cell 
membrane, which leads to very limited internalization.
211, 353-354
 In contrast, cationic 
nanoparticles have been widely demonstrated to bind with negative moieties on cell 
membranes and thus facilitate the movement of substrates across the lipid bilayer.
355
 The 
mechanism of interaction between cationic nanoparticles and cell membranes was 
confirmed by AFM investigation,
356
 and showed that the positive moieties destabilize the 
membrane and cause the formation of pores in defective areas of the membrane. Thus, in 
eukaryote cells, the size, shape, surface charges, and surface functional groups of 
nanoparticles can influence the interaction between nanoparticles and the cell membrane. 
These factors will prove important when targeting intracellular bacterial pathogens.  
 
Drug loading 
 In order to address drug delivery approaches to bacteria, it is useful to examine 
the techniques used to engineer nanoparticles for drug delivery. Generally, the two basic 
approaches used to attach drugs to nanoparticles include covalent and non-covalent 
binding. Both approaches possess specific advantages and disadvantages. Covalent 
binding offers a steady delivery platform, but usually requires pre-treatment of drugs. For 
example, Cheng and colleagues reported the synthesis of phthalocyanine-based 
photodynamic therapy (PDT) using drugs conjugated to gold nanoparticles.
357
 The drug 
release and PDT efficacy are affected by the chemical bond between the drug molecules 
and the Au surface. Specifically, the labile amino adsorption triggers the drug release into 
42 
HeLa cancer cells. In another study, Gu and co-workers reported the synthesis and 
improved activity of vancomycin-conjugated Au nanoparticles against vancomycin-
resistant Enterococci (VRE) and Gram-negative bacteria.
137
 Covalent binding between 
drugs and nanoparticles provides a secure method of binding that lessens drug pre-release 
or leakage. Covalent binding also allows for the drug release speed to be controlled by 
adjusting the breakage rate of the covalent bond. Usually, slow release drug delivery 
strategies employ the covalent binding method.  
 In non-covalent binding strategies, potential drug pre-release or leakage can be 
avoided by using stimulus functionalities on the nanoparticle shell to block or cover the 
drug releasing pores. Baeza and co-workers reported the preparation of 
poly(ethyleneimine)-b-poly(N-isopropylacrylamide) (PEI/NIPAM) coated mesoporous 
silica nanoparticles (MSN) with encapsulated iron oxide nanocrystals to deliver multiple 
drugs simultaneously (Figure 1.5).
184
 The grafted block copolymer was designed to retain 
the drugs inside the NP through temperature-responsive control and by attaching proteins 
into the grafted polymer shell via intermolecular interactions. The use of specific 
functionalities to block nanoparticle pores is an efficient method to prevent drug pre-
leakage. Non-covalent binding provides a straight forward method for drug delivery and 
the decreases the risk of drug pre-leakage.   
 In addition to drug entrapment, other barriers have been designed to minimize 
drug pre-leakage in non-covalently bound nanoparticles. Chen et al. reported a new 
magnetic drug delivery system that utilizes doxorubicin (DOX)-associated Fe3O4 
nanoparticles coated with a polyethylene glycol (PEG) modified porous silica shell 
(Fe3O4-DOX/pSiO2–PEG) to treat tumors.
358
 The DOX-conjugated Fe3O4 nanoparticles 
43 
were embedded in a silica shell and coated with PEG chains (Figure 1.6). After etching 
the thick silica shell, the Fe3O4-DOX/pSiO2–PEG was 150 nm in diameter. The porous 
silica shell presents a physical obstacle that decreases the dissociation rate of DOX from 
the nanoparticle core.  
 Like covalent binding, non-covalent binding provides a direct loading and release 
mechanism. However, drug pre-release or non-specific leakage is frequently noted. To 
counteract this problem, Mortera and co-workers prepared a mesoporous silica 
nanoparticle-based cage-like vehicle to deliver cysteine intracellularly.
178
 The cysteine 
was encapsulated within the nanoparticle and only released when triggered by 
intracellular antioxidants. Similarly, Adeli et al. prepared a hybrid nanostructure with a 
gold core and a polyrotaxane shell.
359
 Both cisplatin and DOX were associated with the 
hybrid nanoparticles, and drug release controlled by photothermal explosion. Similarly, 
Rotello and co-workers reported the synthesis of monolayer-functionalized gold 
nanoparticles with a hydrophobic alkane thiol core and a hydrophilic shell.
185
 The 
hydrophilic shell consisted of a tetra (ethylene glycol) (TEG) component, end-capped 
with a zwitterionic group. Hydrophobic drugs were entrapped in the hydrophobic region 
of the nanoparticle surface monolayer via nonspecific binding and released into cancer 
cells by membrane-induced diffusion. 
  
Controlled drug release 
 A variety of release strategies of nanoparticle drug delivery vehicles have been 
reported, and are controlled by pH, light, temperature, enzymes, or magnetic fields.
179, 185, 
357, 360-363
 The drug release strategies are directly dependent on the drug binding methods. 
44 
For those carriers with covalent binding between nanoparticles and drugs, a low pH 
solution will hydrolyze the covalent bond. For example, Zhang and co-workers prepared 
doxorubicin conjugated Fe3O4 encapsulated in thermo-responsive dextran-g-poly(N-
isopropylacrylamide-co-N,N-dimethylacrylamide) and that conjugated to a 3-
mercaptopropionic acid hydrazide-functionalized nanoparticle via an acid-labile 
hydrazone bond (Figure 1.7).
364
 At a temperature above the lower critical solution 
temperature (LCST), drug release was controlled in a mild buffer solution. Alternatively, 
UV (256 nm) and visible (530 nm) light was used to switch the confirmation of the 
polypeptide backbone of diarylethene-containing cyclic peptidomimics.
365
 Enhanced 
antimicrobial activity was seen with the ‘open’ form of the compound, and completely 
lost in the ‘closed’ form.  
 Carriers that are pH-responsive also provide a controlled drug release for non-
covalently bound nanoparticle and drugs. He and co-workers reported a one-pot self-
assembly strategy to prepare a MSN-based drug delivery vehicle whose release is 
stimulated by pH change (Figure 1.8).
366
  
 Magnetic field, temperature, and light were used to stimulate the drug release 
from their corresponding vehicles. McGill and co-workers reported that magnetic 
nanoparticles can disrupt a viscous extracellular biopolymer under a low oscillating 
magnetic field (OMF) of 295-kHz and enhance the delivery of lambda DNA/HindIII.
367
 
The OMF induced thermal activity of the nanoparticle can enhance its transportation in a 
viscous environment, as well as induce the breakage of DNA to trigger drug release. 
Urbina and co-workers prepared magnetite- poly(methylmethacrylate) (PMMA) and 
cobalt –PMMA nanoparticles with fluorescein isothiocyanate (FITC), and tested drug 
45 
release with magnetic and thermal control.
368
 Ren and co-workers reported the 
modification of Au (shell) - Au2S (core) nanoparticle surface with 11-
mercaptoundecanoic acid (MUA) to load the anti-tumor drug cis-platin.
369
 The loading of 
drug onto Au - Au2S nanoparticles was pH-dependent and the drug release was triggered 
by near-infrared irradiation, which is not harmful to human tissues.  
 
1.5 OVERCOMING THE BACTERIAL BARRIERS OF INFECTIONS: 
NANOPARTICLES AS ANTIMICROBIAL DELIVERY VEHICLES 
 Using NPs as antimicrobial delivery vehicles (ADVs) offers an extraordinary 
potential to control bacterial infections. Most bacterial infections occur as attached 
biofilms, where cells are embedded within a protective matrix of extracellular polymers 
(EPS) that are secreted by the bacteria.
370
 Nanoparticles have shown a strong ability to 
complex to biofilms, and more specifically the EPS matrix of biofilms, both in natural 
environments
371-372
 and under laboratory conditions.
373-374
 In order to treat biofilm-based 
infections with NPs, their physical and chemical properties, primarily size and surface 
chemistry, must be designed to overcome several major hurdles within a biofilm. First, 
NPs must be able to penetrate the EPS matrix in order to reach and destroy the cells 
enveloped within a biofilm. The NP size will limit its ability to diffuse through the EPS, 
while the NP surface properties will dictate the amount of interaction between the EPS 
polymers and the NPs. Therefore, in order to inhibit a biofilm infection, the corona 
surrounding a NP must be tailored to facilitate diffusion through the biofilm EPS to 
resident bacterial cells.
375
 Although there is little research in this area, it has been noted 
that diffusion of NPs through biofilms is affected by the viscosity of the EPS, the 
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variability of cell density, the bulk fluid flow of water, and the external mass transfer 
resistance (stagnant liquid layer on surface of biofilm that slows penetration of solutes) in 
three dimensions. However, the movement of nanoparticles through EPS is a poorly 
understood phenomenon. This section will discuss how NPs are impacted by these 
factors, as related to bacterial biofilms 
 
The biofilm state: a primary hurdle for infection control 
 Many bacteria are now realized to occur as attached structured communities 
called biofilms, where cells are surrounded by a secreted matrix of extracellular 
polymeric substances (EPS).
370, 376
 Biofilms have been recognized to play a major role in 
human health over the past 50 years, as the occurrence of bacterial infections has shifted 
from acute infections, such as cholera and diphtheria, to chronic infections, such as 
MRSA and Pseudomonas aeruginosa. Chronic bacterial infections are generally found in 
the biofilm state, allowing them to evade the immune system and persist through 
antibiotic treatment.
377
 Such biofilm-based diseases are common and include infectious 
kidney stones, bacterial endocarditis, cystic fibrosis airway infections, periodontitis, and 
indwelling medical device infections.
378-379
 A major difficulty in treating chronic 
bacterial infections lies in the biofilm matrix (i.e. EPS) in which the bacteria reside. 
Antibiotics that are able to eliminate planktonic forms of bacteria may require 100- to 
1000-fold higher concentrations to defy the heterogeneous complexity of a biofilm 
matrix, and even then the infection often will persist. Biofilm-associated cells possess a 
number of special adaptations, collectively called ‘insurance effects’, which serve to 




 As seen in Figure 1.9, the biofilm matrix provides nutrients, protection, and 
hydration to a dense community of bacteria. A significant amount of research has been 
devoted to understanding the role and development of the biofilm matrix (for a thorough 
review, see Flemming & Wingender).
376
 In response to environmental conditions, the 
integrity and function of the biofilm changes to ensure survival and persistence of the 
bacteria. The complexity of the matrix is due to its many components, which include 
proteins, lipids, polysaccharides, glycoproteins, glycolipids, membrane vesicles, nucleic 
acids, ions, and, of greatest abundance, water.
382
 EPS also contains many sorption sites
383
 
for potential interactions with nanoparticles and charged molecules. The plasticity of the 
biofilm matrix allows it to fulfill the roles of protector, electron donor/acceptor, anchor, 
and retainer of nutrients, enzymes, energy, and genetic material under dynamic 
conditions.
376
 A recent study has suggested that the EPS of the biofilm matrix contributes 
to an osmotic gradient in the matrix and drives biofilm spreading.
384
 In addition to a 




 While occasionally biofilms can consist of a clonal population of one bacterial 
species, they most often occur as a population of many, diverse bacterial species.
386
 
Under both circumstances, gene expression varies throughout the biofilm in response to 
environmental conditions, resulting in localized areas of specific cell activity.
387
 For 
example, the bacterium P. aeruginosa modifies gene expression to control alginate 
production and motility in response to biofilm aggregation.
388
 Even within the EPS itself 
there is much heterogeneity in its physical structure
389
 owing to the existence of 
microdomains,
390-391
 which may contribute to diffusive transfer. Specific extracellular 
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polysaccharides (e.g. PsI) are now related to attachment and biofilm formation in P. 
aeruginosa.
392-393
 Similarly, Staphylococcus aureus has been shown to regulate key 
structural biofilm components via gene regulation throughout biofilm development.
394
 
The ability to display multiple spatiotemporal phenotypes throughout biofilm formation 
is a survival technique used by bacteria to colonize surfaces and establish an infection. 
The microenvironment created by the gradient of matrix components throughout the 
biofilm allows bacterial cells to thrive and persist under adverse conditions once the 
biofilm has been established. An excellent review of biofilm initiation and development 




Challenges for inhibition of biofilms using engineered nanoparticles 
 It is reasonable to assume that diffusion is a requirement for substantial biofilm 
growth (i.e. how else can nutrients (to cells) and wastes (from cells) move within a 
biofilm?). Using time-lapsed confocal scanning laser microscopy, the time of penetration 
for a 10 kDa molecule to reach the center of a cell cluster was estimated to be 3 
minutes.
395
 The inherent complexity of a bacterial biofilm makes it easy to underestimate 
nanoparticle mobility and difficult to standardize diffusion coefficients. Diffusion models 
must consider the 1) viscosity of the EPS, 2) the variability of cell density, 3) the bulk 
fluid flow of water, 4) interactions of the solute with the EPS (i.e. diffusion reaction 
constraints), 5) the sizes (and volumes) of water spaces between EPS molecules, and 6) 
the external mass transfer resistance (stagnant liquid on top layer of biofilm that slows 
penetration of solutes) in three dimensions. 
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The EPS matrix hurdle: a physical barrier to nanoparticle diffusion 
 Both simple and complex models have been developed to determine the rate at 
which molecules and/or nanoparticles of a particular size can permeate through and 
diffuse within a biofilm of a particular viscosity and composition.
396-398
 The rapidly 
developing field of nanotechnology offers an alternative method to treating biofilm 
infections, and functionalized nanoparticles have the potential to efficiently deliver 
antimicrobial compounds to microbial cells within a biofilm.  
 Diffusion through the EPS matrix is a complex process. Currently, it is thought 
that small molecules diffuse through both pure water and EPS at approximately the same 
rate. The EPS matrix consists of mostly free water that is immobilized within pore spaces 
between a framework of polymeric molecules.
399-400
 Given that small molecules and 
nanoparticles often move freely through the water, the limiting factor in their movement 
through biofilms is directly related to interactions with the EPS matrix polymers. Many 
diffusion rates of small molecules have been measured in various types of biofilms with 
values ranging from 0.9 to 0.2, when compared with diffusion through pure water.
401-405
 
Using our knowledge of small molecules in biofilms, the movement of nanoparticles in 
biofilms can be studied. 
 Currently, a key criterion in the design of nanoparticles intended to penetrate a 
bacterial biofilm is the size and charge of the nanoparticle. Recent studies have shown 
that nanoparticles are able to diffuse through a biofilm; however, the rate of diffusion has 
been directly related to the size of the nanoparticle.
395-398, 401, 403, 406-410
 As such, a final 
hurdle involves the design of nanoparticle size and surface properties that will facilitate 
their penetration into a biofilm matrix. 
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 Several publications have suggested that the connectivity and size of pores within 
a biofilm influences the speed and penetration of nanoparticles. Hindrances such as a 
porous biofilm, local accumulation of nanoparticles on bacterial cells and large 
macromolecules, the nonspecific adsorption of nanoparticles to freely diffusing species, 
abiotic particles, and gas all play a role in preventing efficient diffusion of 
nanoparticles.
397
 Studies have been conducted to show that larger nanoparticles diffuse 
slower through biofilms because they get trapped in pores, cell aggregates, and the 
general biofilm matrix more than their smaller counterparts.
406-407
 Peulen et al. 
demonstrated that 57 nm, 92 nm, and 135 nm nanoparticles had little success with 
penetration in a dense biofilm.
397
 They concluded that the effective pore size in loose 
biofilms is approximately 50 nm, which translates to efficient diffusion for nanoparticles 
near 10 nm in diameter. Hidalgo et al. showed that nanoparticles of up to 70 nm could 
penetrate a bacterial biofilm; however, they also showed that nanoparticles measuring 
less than 30 nm were most effective at homogenously filtering through the matrix.
409
 
Steric hindrance by the biofilm matrix does not play a major role in nanoparticle 
diffusion, and therefore does not influence the rate at which nanoparticles diffuse through 
a biofilm.
403
 Currently, a key criterion for designing nanoparticles that will effectively 
penetrate and target bacterial cells within a heterogeneous biofilm will be size 
manipulation.  
 
Enhanced antibiotic resistance in biofilms: physiological and genetic 
 The phenotypic, genotypic, and physical complexities of a bacterial biofilm 
present many challenges to modern medicine. In general, bacterial antibiotic resistance 
51 
occurs as a consequence of genetic mutation, acquisition of antibiotic resistance genes, 
and/or horizontal gene transfer.
411-412
 Antibiotic resistance and antibiotic resistance genes 
have been present in bacterial genomes throughout their evolution. A study from 2004 
showed that serine -lactamase (an enzyme capable of inactivating -lactam antibiotics) 
genes originated nearly 2 billion years ago, and have been present on plasmids for 
millions of years.
413
 Most antibiotic producing organisms carry genes that encode 
antibiotic resistance to ensure self-protection;
414-415
 such genes are usually found in the 
same gene cluster as the antibiotic synthesis genes.
416-417
 A thorough review of the 




 In addition to genomic manipulations, mechanisms of antibiotic resistance within 
a biofilm are also related to restricted antibiotic penetration,
419-423
 decreased bacterial 
growth rates and metabolism,
423-426
 quorum sensing and induction of a biofilm-specific 
phenotype,
172
 induction of stress response genes,
427-428
 and an increase in the expression 
of efflux pumps. These mechanisms are referred to as non-inherited resistance, and are 
intrinsic phenotypic characteristics of bacteria in a biofilm or structural obstructions of 
the biofilm matrix.
411, 429-430
 A detailed analysis of antibiotic resistance in biofilms has 
been reviewed by Høiby et al.
431
  
 Kirby et al. developed a method to assess the contribution of the physical 
structure to the phenotypic resistance of biofilms, without genetic or chemical methods 
that could be confounded by pleiotropic effects.
429
 Their study demonstrated that during 
high cell densities, planktonic cultures exhibited similar levels of antibiotic resistance as 
biofilm cells; however, the cells released from biofilms were individually more 
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susceptible to antibiotics that target the cell membrane components (colistin) or depend 
on membrane function for uptake (gentamicin, streptomycin) than their planktonic 
counterparts. They suggest that the cell membrane of biofilm bacteria may be more 
sensitive to antibiotics than the cell membranes of planktonic bacteria. Their results 
indicate the both cell membrane physiology and the structure of the EPS matrix plays a 
role in antibiotic resistance within biofilms.  
 The diverse nature of biofilms also enhances resistance to antibiotics, as seen 
when mixed biofilms of Candida albicans and S. aureus more effectively resist 
vancomycin than either as mono-biofilms or mono-planktonic cultures.
432
 Social 
interactions are essential for successful multicellular complexity.
433
 The ability of 
bacteria to interact within a biofilm allows the cells to maintain a more-stable 
environment that confers antibiotic resistance via horizontal gene transfer,
434-435
 the 
sharing of common resources,
436-437
 and the regulation of core sets of genes.
438
 The 
physiological heterogeneity of a bacterial biofilm makes it extremely pliant and 
adaptable, and incredibly difficult to combat and eliminate. However, this complexity 
also offers a variety of targets for researchers to exploit. 
 A recent review by Yang et al. discussed current approaches that are used to 
eliminate bacterial biofilms.
439
 The review focused on biochemical approaches such as 
antimicrobial agents and peptides, physiochemical approaches such as modifying 
industrial surfaces with anti-adhesive and microbicidal agents, biological approaches 
such as inhibiting biofilm formation with the use of natural products found in mixed 
culture biofilms, and approaches that directly interfere with structural development and 
differentiation within a biofilm such as eliminating EPS production or inhibiting the 
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ability of bacteria to socially interact via quorum sensing inhibition. In an effort to 
combine these many approaches, the development of functionalized nanoparticles has 
been investigated.  
 While the formulation of nanoparticles is well established and continues to be 
improved upon, their applications to target bacteria and the exact mechanisms of action 
are less well understood. A recent study by Decho, Benicewicz, and colleagues found that 
when complexed to SiO2 nanoparticles, the common antibiotic penicillin-G is effective in 
killing penicillin-resistant strains of bacterial pathogens, including strains of methicillin 
resistant Staphylococcus aureus (MRSA), at low total concentrations.
440
 The authors 
termed this effect the ‘grenade hypothesis’ and postulated that each nanoparticle delivers 
a concentrated package of antibiotic to a given cells, perhaps overwhelming its resistance 
mechanism (e.g. beta-lactamase enzymes), which are normally used in defense against 
the antibiotic. While this hypothesis remains to be confirmed, the use of nanoparticles as 
antibiotic-delivery vehicles (ADVs) is an emerging area of exploration. 
 
1.6 CONCLUSION  
Nanoparticle-based delivery of antibiotics is being proposed, and developed, as a highly-
efficient means to deliver antibiotics and target bacterial infections. It offers the 
possibility to deliver high concentrations of antibiotics, and thus overwhelm bacterial 
antibiotic resistance strategies.  The future efficacy of nanoparticle-based delivery of 
antibiotics rests upon the ability of nanoparticles to localize a high-concentration of 
drugs, reach a pre-determined target with high specificity and efficiency, and release 
those drugs in a controlled and timely manner without toxic effects to in vivo host cells. 
54 










Figure 1.1 Diagram of cell walls of Gram-positive and Gram-negative bacteria.
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Figure 1.2 A schematic illustration showing the loading and release mechanism of an 
anionic drug in TA modified MSN (a) Before the drug is adsorbed, (b) after drug 
adsorption, (c) electrostatic repulsion triggering drug release, and (d) ion-exchange 






Figure 1.3 (a) A schematic illustration showing the controlled drug release of a 
pNIPAAm-grafted Au nanocage by adjusting a near-infrared laser to generate heat and 
release the entrapped contents; (b) Atom-transfer radical polymerization (ATRP) of 
















Figure 1.5 The schematic illustration of multidrug release by MSN-polymer 








Figure 1.6 The schematic illustration of the synthesis of DOX-associated Fe3O4 















Figure 1.8 A schematic illustration showing the one-pot self-assembly strategy for 






Figure 1.9 A biofilm is composed of attached microbial cells encased within a matrix of 
extracellular polymeric secretions (EPS), which surround and protect cells. The EPS 
matrix is typically composed of polysaccharides, proteins, lipids, and extracellular DNA 
(eDNA). Localized within the EPS matrix (see figure inset) are extracellular enzymes (e-
Enzymes). Also present are small pieces of DNA carrying specific genes, called 
plasmids. Both e-Enzymes and plasmids are protected against degradation with the 
biofilm. Finally, bacteria release signal molecules for a process of chemical 
communication called quorum sensing. A biofilm may extend from just a few to 
hundreds of micrometers above a surface, but is equipped with many inherent adaptations 









FUNCTIONALIZED NANOPARTICLES SILENCE BACTERIAL COMMUNICATION 
 
Excessive use of antibiotics has resulted in an increased rate of bacterial resistance and 
poses a significant public health threat. As a result, non-cytotoxic methods of controlling 
bacterial infections, such as interference in bacterial communication (i.e. quorum 
sensing), are necessary to avoid resistance against antimicrobial therapies.
441
 Quorum 
sensing (QS) is a chemical signaling scheme used by bacteria to communicate and 
coordinate their activities within a biofilm. Figure 2.1 displays a common structure of a 
chemical signal used by bacteria during communication. QS regulates the features that 
make bacteria dangerous, such as biofilm formation, virulence factor production, and 
uptake of antibiotic resistant genes.
431, 442-443
 
The goal of this chapter was to develop functionalized nanoparticles that will 
weaken the communication network of bacteria, rather than target the viability of cells, in 
order to fight pathogenic infections while limiting the risk of antibiotic resistance. To 
accomplish this I used functionalized silicon dioxide nanoparticles (Si-NPs) to quench 
the small, diffusible signal molecules (e.g. Figure 2.1) that bacteria rely on to 
communicate and coordinate their activities. The functionalized Si-NPs are added to 
bacterial cultures and bind the chemical signals as they diffuse between cells.
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Sequestering these signals via functionalized nanoparticles and subsequently blocking 
bacterial communication can potentially prevent activities such as pathogenesis, 
adhesion, and biofilm formation. This chapter describes the growth and transcription 
studies used to demonstrate that this anti-virulence technology controls bacterial 
infections by directly influencing bacterial communication and subsequent activities 
regulated by quorum sensing.  
Inspired by developments in the field of drug delivery, nanoparticles have been 
designed to carry compounds that will quench signal molecules. Removal of signals from 
the immediate bacterial environment prevents the molecule from reaching its cognate 
receptor, thus inhibiting the signal/receptor interaction, and interfering with down-stream 
regulation. In theory, this process will quench signal molecules and “turn off” quorum 
sensing and silence bacterial communication. -cyclodextrin (-CD) is a compound that 
nonspecifically binds N-acyl-L-homoserine lactone molecules,
444-445
 a common class of 
signal molecules produced by Gram-negative bacteria. -CD consists of seven 
glucopyranose units bound by -1,4-glycosidic linkages (Figure 2.2).  
 This molecule takes the shape of a truncated cone with a hydrophilic exterior and 
a slightly hydrophobic interior. -CD was chosen as a model compound because the 
formation of a CD complex can often be detected and because the reactivity of a guest 
molecule in a CD complex is often modified.
446
 In many cases, the CD accelerates the 
various reactions associated with the guest molecule and modifies the reaction pathway. 
Herein we present a new approach to disrupting bacterial quorum sensing with silicon 
dioxide nanoparticles that have been surface-functionalized with -CDs. 
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2.1 CHARACTERIZATION OF MONOLAYER NANOPARTICLES 
The unique properties of surface-functionalized nanoparticles make them ideal for 
targeting the multiple avenues of bacterial defenses and weakening an infection. Surface 
functionalization plays a critical role in tailoring the properties of nanoparticles via well-
developed surface chemistry.
254, 447
 A method has recently been developed for the 
synthesis of carboxylic acid-coated silicon dioxide nanoparticles with a controllable 
functionalized surface.
284-285
 Using this method, monolayer -CD coated fluorescent 
silicon dioxide nanoparticles were synthesized via a coupling reaction between the 
hydroxyl groups of -CD and a monolayer dye-labeled carboxylic acid coated silicon 
dioxide nanoparticle. A representation is seen in Figure 2.3. 
The carboxylic acid coated nanoparticles were prepared based on a ring opening 
reaction between succinic anhydride and amino-functionalized silica nanoparticles with a 
variety of surface graft densities ranging from 0.24-0.65 groups/nm
2
. Thus, the graft 
density of -CD functionalized nanoparticles can be tailored by varying the feed ratio 
between bare silica nanoparticles and amino-silane compound. The as-synthesized -CD 
functionalized nanoparticles were purified via dialysis to remove un-reacted free -CD 
molecules, as confirmed by 
1
H NMR (Figure 2.4). Additionally, thermogravimetric 
analysis (TGA) confirmed that the monolayer -CD accounted for 2.78% of the total 
weight for particles having a surface graft density of 0.24 groups/nm
2
 (Figure 2.5). The 





2.2 CHARACTERIZATION OF POLYMER NANOPARTICLES 
In addition to monolayer -CD coated nanoparticles, polymer coated 
nanoparticles were also tested. Polymer grafted silica nanoparticles containing -CD side 
groups were prepared via the condensation reaction between the grafted poly(methacrylic 
acid) and the hydroxyl groups on -CD. A schematic representation is seen in Figure 2.6. 
The dye-labeled poly(methacrylic acid) grafted silica nanoparticles were prepared 
by direct surface-initiated RAFT polymerization of methacrylic acid on dye-labeled silica 
nanoparticles. Thus, the carboxylic acid loading can be controlled by tailoring the surface 
grafted poly(methacrylic acid) brushes length as well as the graft densities. TGA data 
showed that the surface polymer supported chains with multiple -CD accounted for 
61.7% by weight for particles that have a PMAA brush density of 0.18 chains/nm
2
 and 
molecular weight of 54,900 mol/g (Figure 2.7). The -CD side chain based polymer 
grafted nanoparticles showed strong fluorescence under UV light, even after multiple-
step surface chemical modifications (Figure 2.8).  
 
2.3 NMR DETECTS BINDING OF HSLS AND -CYCLODEXTRIN 
The NMR diffusion measurements were used to provide insight into the binding 
of N-octanoyl-L-homoserine lactone (C8-HSL) to both -cyclodextrin and -
cyclodextrin. The data for various concentrations of C8-HSL and CD are summarized in 
Table 2.1. The observed diffusion coefficients (D) are the average values that were 
determined for each 
1
H resonance arising from the two compounds. While the D of the 
cyclodextrins in each solution remains unchanged (within experimental error), the D of 
C8-HSL decreases towards the D of CD as the ratio of CD to HSL is increased. In the 
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case of a large excess of CD, the equilibrium of C8-HSL shifts to the bound form and the 
D of C8-HSL is the same as the CD. This indicates that all of the C8-HSL is in the bound 
form.  
It is important to note that NMR diffusion data for the HSL can be fit with a 
single exponential function and there is no evidence of two diffusing forms, i.e., free and 
bound. Therefore, the data suggests that during the timeframe of the NMR experiments 
(100s msec) the HSL is rapidly moving between free solution and bound into the CD and 
an equilibrium of the two forms exists.  
The observed diffusion coefficient (Do) for the C8-HSL in these mixtures is a 





 Do = Ff Df + Fb Db (1) 
 
where Ff is the fraction of C8-HSL that is free and Fb is the fraction that is bound. The 
dissociation constant can be calculated from the measured diffusion coefficient and the 
starting concentrations of the two species by:  
 
Kd = [CD] 
Db – Do 
+ [C8-HSL] 
Do – Db 
(2) 
Do – Df Db – Df 
 
Since diffusion coefficients are sensitive to variations of temperature and sample 
viscosity, comparisons across samples are difficult. However, the observed diffusion 
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coefficients (Do) can be corrected using the diffusion of water in each sample and 
comparing that to a standard value. For this study we corrected each Do with that of the 
H2O measured in the solution of only C8-HSL. 
 
 DCorr = Do DH2O / DH2O-C8-HSL (3) 
 
 The calculated values of Kd for each of the solution are included in Table 2.1. The 
three values for the -CD are in close agreement with each other (average = 1.50 x 10
-3
 
M). This value is 7.5 times higher than that of the -CD. Expressed differently, C8-HSL 
binds 7.5 times stronger in the -CD than the -CD (Ka = 1/Kd). The smaller interior of 
the -CD is a better fit for the C8-HSL. This procedure was also used to determine the 
diffusion coefficient for 3OC6-HSL and -CD; however, initial attempts were 
unsuccessful and did not indicate binding.  
The binding strength between -CD and HSLs was determined, although -CD 
was strictly used as a model binding agent and will eventually be replaced with a highly-
specific compound. NMR diffusion experiments demonstrated that both C8-HSL 
(produced by V. fischeri) and C6-HSL (produced by Pseudomonas aeruginosa) could 
bind to -CD in a 1:1 ratio; however, there was no evidence that 3OC6-HSL (also 
produced by V. fischeri) formed a complex with -CD. Further calculations revealed the 
binding and dissociation constants of the experimental complexes. As seen in Table 2.2, 
there was weak binding between the HSLs and -CD with 17% of C6-HSL and 35% of 
C8-HSL bound to -CD at any one time in the 1:1 solution. After demonstrating that the 
formation of a -CD/HSL complex was possible, we sought to quantify the quenching 
67 
ability of -CD in vitro. Using growth and luminescence studies we observed the 
influence of -CD on V. fischeri bioluminescence.  
 
2.4 -CYCLODEXTRIN QUENCHES HSLS IN VITRO 
To test the quorum quenching function of these nanoparticles, the marine 
bacterium Vibrio fischeri was employed as a model. V. fischeri relies on N-acyl-L-
homoserine lactone molecules to trigger coordinated activities such as colonization and 
bioluminescence in a threshold dependent manner.
449
 Specifically, V. fischeri synthesizes 
and responds to N-3-oxo-hexanoyl-L-homoserine lactone (3OC6-HSL)
450-451
 and N-
octanoyl-L-homoserine lactone (C8-HSL) (Figure 2.9)
452
 via the lux operon, which is also 
responsible for the proteins that synthesize luminescent luciferase.
453
 This quorum 
sensing function allows V. fischeri to establish a symbiotic relationship with the 
Hawaiian bobtail squid (Euprymna scolopes) in their natural ocean habitat.
454
  
Environmental conditions are essential for the proper functioning of V. fischeri 
bioluminescence. A symbiotic culture produces approximately 1000-fold brighter 
bioluminescence and more 3OC6-HSL than cultured cells at the same density.
455
 
Therefore, HSLs are added to the cultures in vitro to induce quorum sensing and visible 
bioluminescence. Figure 2.10 portrays V. fischeri cultures induced with high levels of 
3OC6-HSL and C8-HSL.   
V. fischeri cultures grown in the presence of 2 M 3OC6-HSL exhibited strong 
bioluminescence and normal growth. When treated with concentrations of free -CD 
ranging from 250 nM to 7 mM, the growth study showed that exposure to 2 mM  -CD 
resulted in the most significant decrease in bioluminescence (Figure 2.11). A preliminary 
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analysis of -CD functionalized nanoparticles with 2 M 3OC6-HSL demonstrated that 
-CD was significantly more effective at dimming bioluminescence of V. fischeri when 
functionalized as a monolayer to a nanoparticle than it was as a free compound (diagram 
in Figure 2.12, results in Figure 2.13). In contrast, the -CD polymer coated nanoparticles 
did not have a significantly different effect than free -CD on luminescence (Figure 
2.14). Because 2 M 3OC6-HSL exceeds the expected HSL production of symbiotic 
V.fischeri cultures, and does not induce the lux operon like C8-HSL, we altered the HSL 
conditions to mimic the natural environment.  
Growth experiments were repeated with V. fischeri cultured with 125 nM 3OC6-
HSL and 0.25 nM C8-HSL. Optical density and bioluminescence were monitored 
throughout growth to determine the impact of free and functionalized -CD. All cultures 
were grown in defined minimal medium,
456
 and therefore were not in a rich nutrient 
environment. Additional growth studies indicated that the bacteria did not thrive on -CD 
or the various Si-NPs. Also, when all carbon sources in the defined minimal medium 
were replaced with -CD, no growth occurred. Cultures grown without the addition of 
HSLs produced negligible levels of bioluminescence. Therefore, -CD, with or without 
NPs, did not influence the growth or health of the cells.  
V. fischeri cultures grown in the presence of 125 nM 3OC6-HSL and 0.25 nM C8-
HSL produced measureable bioluminescence; although, bioluminescence in general was 
lower compared to the cultures treated with 2 M 3OC6-HSL (as indicated by the 
different scales in Figure 2.13 and Figure 2.15). Our study found that at environmentally 
relevant levels of HSLs, bioluminescence was significantly reduced in vitro by -CD. By 
functionalizing -CD to 50 nm NPs, 133 nM -CD was able to produce the same result as 
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a 2x higher concentration of free 250 nM -CD (Figure 2.15). We found that 15 nm Si-
NPs with or without -CD decreased bioluminescence to the same extent, and thus may 
not have a significant role in dimming luminescence.  
The long half-life (relative to a 12-hour growth experiment) of luciferase likely 
contributed to the uncertainty in discerning subtle changes in quorum sensing over time. 
To further examine the role of functionalized and free -CD in V. fischeri quorum 
sensing, we then examined changes in transcription of the lux operon during exposure to 
-CD and -CD functionalized Si-NPs. 
 
2.5 TRANSCRIPTION OF THE lux OPERON DURING NANOPARTICLE 
EXPOSURE 
Bioluminescence in V. fischeri is generated by the lux operon and is activated by 
3OC6-HSL and C8-HSL. Transcription of the lux operon results in the production of 
luciferase, the enzyme responsible for bioluminescence. In this study, the fold change in 
luxA and luxR transcription was quantified to determine the activity of the lux operon 
during exposure to -CD. LuxA forms the alpha subunit of luciferase and was used to 
monitor bacterial luminescence. LuxR is a receptor for both 3OC6-HSL and C8-HSL, 
and initiates the lux operon, and was used to monitor signal production. Table 2.3 
summarizes the fold-changes calculated from the Ct values generated by qPCR with the 
Livak method (ΔΔCt) of both HSL-treated cultures.  
The quantity of transcripts produced by untreated cultures (controls) and cultures 
treated with 250 nM -CD were not markedly different, indicating that low 
concentrations of free -CD are ineffective in down-regulating luxA and luxR at 
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environmental levels of HSLs (data not shown). The addition of much higher (i.e. 2 mM) 
-CD significantly reduced the expression of luxA and luxR transcripts, as indicated by 
the calculated fold changes. In an attempt to more-efficiently deliver -CD to the 
bacterial cell, low concentrations of -CD were delivered via Si-NPs. As Table 2.3 
indicates, both the functionalized and non-functionalized 15 nm Si-NPs reduced the 
expression of luxA and luxR transcripts to a similar extent. The data agree with the 
growth study, indicating that the influence of 15 nm Si-NPs and 155 nM -CD 
functionalized 15 nm Si-NPs is indistinguishable. Conversely, treatment with the larger 
nanoparticles (i.e. functionalized and non-functionalized 50 nm Si-NPs) resulted in 
significantly different fold changes. The 133 nM -CD, when bound to functionalized 50 
nm Si-NPs, resulted in the greatest down-regulation of luxA and luxR transcripts out of all 
treatments, demonstrating the strong utility of this size of functionalized silica 
nanoparticles. The discontinuity of the bioluminescence measurements between the 
growth and transcription studies was likely influenced by the relatively long half-life of 
bioluminescence, which contributed to an inability to discern differences using 
bioluminescence during growth.  
The growth and transcription studies indicate that the 15 nm and 50 nm Si-NPs 
resulted in different levels of bioluminescence, although both Si-NPs were synthesized 
using the same method. Based on the nanoparticle synthesis methods and TGA analyses, 
we determined that the 15 nm Si-NPs carry 0.06 mol -CD / mg Si-NP complex, while 
the 50 nm Si-NPs carry 0.15 mol -CD /mg Si-NP complex, indicating that the surface 
densities of the two Si-NPs are different. Additionally, the surface area of the 50 nm Si-
NPs is more than ten times the surface area of the 15 nm Si-NPs, which may have 
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provided for more space between individual -CD molecules and allowed for more 
efficient binding with the HSLs. Given that a 50 nm Si-NP can carry 1.7 times more -
CD than a 15 nm Si-NP, a higher dose of 15 nm Si-NPs was used to treat the samples to 
achieve comparable levels of -CD. Three major possibilities exist to explain this. First, 
the higher concentration of Si-NPs aggregated in solution, making more of the functional 
groups unavailable on this size Si-NP. Alternatively, the -CD may have been too dilute 
among the 15 nm Si-NPs and therefore did not act differently than dissolved -CD. 
Lastly, it is possible that the 15 nm Si-NPs behave differently than 50 nm Si-NPs in an 
aqueous solution.
349, 457
 It has been shown that the surface modifications of silica affect 
the dispersion of Si-NPs, and that smaller-sized Si-NPs have unique physicochemical 
properties and optical absorption characteristics.
458
 Therefore, smaller nanoparticles with 
a low surface density may behave differently than larger nanoparticles with a higher 
surface density. In summary, it is likely that the -CD dose carried by the 15 nm Si-NPs 
behaved differently than the 50 nm Si-NPs, and therefore was unable to impact quorum 
sensing more significantly than free -CD. The larger 50 nm Si-NPs, in contrast, were 
able to carry a higher dose of -CD on fewer nanoparticles, and directly influenced 
quorum sensing in V. fischeri. 
 
2.6 CONCLUSION 
In this study, we have demonstrated that functionalized silica nanoparticles can be 
used to enhance the role of quenching agents in vitro. Specifically, we demonstrated that 
-CD is able to bind HSLs and down-regulate bacterial quorum sensing genes. We have 
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found that the quenching ability of -CD was much greater on functionalized 50 nm Si-
NPs, and provides a strong model for future designs. 
The growth experiment was conducted with several forms of cyclodextrin to 
determine an efficient binding agent for HSLs. We found that -cylodextrin and 2-
hydroxypropyl--cyclodextrin did not silence bacterial communication any more or less 
efficiently than -cyclodextrin. However, we found that both 125 nM and 250 nM 
methyl--cyclodextrin dimmed luminescence in vitro by 31.8% and 48.9%, respectively, 
while 250 nM -cyclodextrin dimmed luminescence by 16.7% (calculated from data in 
Figure 2.15). When functionalized to a nanoparticle, lower levels (133 nM) of -CD 
dimmed luminescence by 33.3%. We are currently designing nanoparticles to carry low 
levels of methyl--cyclodextrin in an effort to enhance the potency of the Si-NP complex. 
In addition to more specific binding agents, we are also pursuing bacterial receptor 
proteins that will bind signal molecules with high species specificity.  
The importance of nanoparticle therapies is imperative to the treatment of biofilm 
infections. One of the most significant challenges in the treatment of chronic infections is 
delivering effective drugs to bacterial biofilms. Biofilms are surface-associated bacterial 
communities living in a highly organized structure at a liquid interface,
459-460
 and have 
been estimated to be responsible for 80% of hospital-acquired infections.
460
 The 
protective nature of bacterial biofilms makes them able to physically limit antibiotic 
penetration,
419, 421, 423, 461
 quickly regulate multidrug efflux pumps
431, 460
 and stress 
response genes,
462-463
 induce a biofilm-specific phenotype,
423-424, 426
 and easily trade and 
enhance antibiotic resistance genes among their bacterial members.
435, 464
 Here, with the 
advent of nanotechnology, we have demonstrated a unique ability (and tool) to 
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specifically target bacterial communication, which may be used to penetrate infectious 





NMR diffusion measurements were performed on a Varian Mercury/VX 400 
spectrometer operating at 400.273 MHz (
1
H). Pulsed-field gradient spin echoes with 
varying gradient intensity were collected with the Doneshot pulse sequence that was 
included with VNMRJ 2.2D software.
465
 The standard Varian Performa I pulsed field 
gradient amplifier and 5 mm broadband probe were capable of producing a maximum of 
20 gauss/cm field gradients. Spectra were taken at ambient temperature with bipolar 
gradient pulses of 4 ms and a diffusion delay of 100 ms. All data processing was done 
with the Varian DOSY software package. 
 
GROWTH STUDIES 
Bacteria and Growth Media 
V. fischeri JB10 is a derivative of the ES114 strain that contains a chromosomal 
gfp reporter within the lux operon, resulting in luxI-gfp-CDABEG.
466
 The strain was 
prepared and obtained from Professor Eric Stabb (Univ. Georgia, Athens, GA). V.fischeri 
JB10 was cultured from a glycerol stock and grown in marine broth (Difco 2216) to 
exponential phase. The cells were then transferred to defined minimal medium
456
 for an 
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optical density of approximately 0.1 (Abs600nm) for the growth and RNA extraction 
experiments.  
 
Bioluminescence response during exposure to nanoparticles 
V. fischeri JB10 was grown in marine broth to exponential phase and then 
transferred (0.5%) to a defined minimal medium.
456
 For growth experiments, 96-well 
plates were incubated at 28°C in a Victor X Multilabel plate reader for 24 hours. Optical 
density was measured at 600 nm and GFP fluorescence was measured with a 485/20 nm 
excitation filter and a 528/20 nm emission filter. Bioluminescence was also measured. All 
measurements were conducted every two hours for 24 hours following 10 seconds of 
vigorous shaking. The total volume of each well was 200 L, which included either 250 
nM -cyclodextrin, 2 mM -cyclodextrin, 15 nm SiO2 nanoparticles (2.75 x 10
-3
 mg/mL 
NPs), 15 nm SiO2 nanoparticles functionalized with 155 nM -cyclodextrin (2.75 x 10
-3
 
mg/mL NPs), 50 nm SiO2 nanoparticles (8.9 x 10
-4
 mg/mL NPs), or 50 nm SiO2 
nanoparticles functionalized with 133 nM -cyclodextrin (8.9 x 10
-4
 mg/mL NPs). 
Cultures also included 125 nM 3OC6-HSL, 0.25 nM C8-HSL, or both 125 nM 3OC6-
HSL and 0.25 nM C8-HSL. All treatments were added at time zero. A growth experiment 







QUANTITATIVE PCR AND TRANSCRIPT ANALYSIS 
lux transcription during exposure to nanoparticles 
V. fischeri JB10 was grown in marine broth to exponential phase and then 
transferred (1%) to a defined minimal medium.
456
 Cultures were grown at 28°C and 200 
rpm in 250 mL shake flasks with a working volume of 50 mL for 8 hours. Treatments 
were added at 8 hours and exposure/growth continued for 4 hours. At 12 hours of total 
growth, 2 mL of cells were harvested by centrifugation at 2000 x g (5 min). Cells were 
treated with 2 mg/mL lysozyme in TE buffer for 10 minutes and then homogenized with 
a needle and syringe. RNA was extracted with PureLink RNA Mini Kit (Ambion) and 
on-column DNA digestion was performed with PureLink PCR Micro Kit (Invitrogen). 
qPCR was performed on a BioRad CFX96 Real Time System with a C1000 Thermal 
Cycler. Data was analyzed by the Livak method (∆∆Ct) and fold changes were 
determined by using 2
-∆∆Ct
. 
Primers were designed for luxR and luxA with NCBI’s Primer-BLAST. Primers 
for 16srRNA were found in the literature.
467
 All primers were ordered from Integrated 
DNA Technologies (Coralville, Iowa) and are listed in Table 3.4. Genomic DNA from V. 
fischeri JB10 was amplified with the primers and sequenced by Selah Genomics 
(Columbia, SC) to check the accuracy of the primers. 
 
NANOPARTICLE SYNTHESIS  
Materials 
All chemicals were obtained from Fisher or Acros and used as received unless 
otherwise specified. Trimethylsilyldiazomethane (2.0 M in hexanes) was obtained from 
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TCI. 4-Cyanopentanoic acid dithiobenzoate (CPDB) anchored silica nanoparticles were 
prepared according to the literature.
285, 314
 3-aminopropyldimethyl-ethoxysilane was 
obtained from Gelest, Inc. (Morrisville, PA).  Methacrylic acid (99.5%, Acros) were 
purified by passing through an activated neutral alumina column. AIBN was 




H NMR was conducted using CD3OD as the solvent with a Varian Mercury/VX 
400 spectrometer. Molecular weights and PDI were determined using gel permeation 
chromatography (GPC) equipped with a 515 HPLC pump, a 2410 refractive index 
detector, and three Styragel columns. The columns consisted of HR1, HR3 and HR4 in 
the effective molecular weight ranges of 100-5000, 500-30000, and 5000-500000, 
respectively. The GPC used THF as eluent at 30 °C and a flow rate of 1.0 mL/min, and 
was calibrated with poly(methyl methacrylate) standards obtained from Polymer 
Laboratories. Samples were filtered through microfilters with a pore size of 0.2 μm 
before injection. Infrared spectra were determined with a BioRad Excalibur FTS3000 
spectrometer. UV-vis spectra were measured with a Perkin-Elmer Lambda 4C UV-vis 
spectrophotometer. Infrared spectra were recorded with a PerkinElmer Spectrum 100 
spectrometer. Thermogravimetric analysis (TGA) was conducted using a SDT Q600 
TGA system (TA Instruments) with a temperature ramping from 25 °C to 900 °C at a rate 




Preparation of monolayer dye-labeled -CD functionalized silica nanoparticles 
A DMF solution of -CD (70.56 mg, 62.16 mol), N,N'-dicyclohexyl 
carbodiimide (DCC, 10.3 mg, 49.73 mol) and 4-dimethylaminopyridine (DMAP, 
0.5063 mg, 4.144 mol) were added to a 15 mL DMF solution of dye-labeled carboxylic 
acid-functionalized silica nanoparticles (graft density: 0.24 groups/nm
2
, 0.7281g). The 
reaction was stirred at room temperature overnight. The reaction solution was then 
poured into 200 mL ethyl ether followed by centrifugation at 3000 rpm for 5 min. The 
recovered particles were then redispersed in 20 mL of ethanol and subjected to dialysis 
process to further remove impurities. The dye-labeled -CD coated silica nanoparticles 




Preparation of polymer dye-labeled -CD grafted silica nanoparticles 
 A DMF solution of -CD (3.711 g, 3.27 mmol), N,N'-Dicyclohexylcarbodiimide 
(DCC, 0.54 g, 2.616 mmol) and 4-Dimethylaminopyridine (DMAP, 26.6 mg, 0.218 
mmol) were added to a 10 mL dry DMF solution of dye-labeled poly(methacrylic acid) 
grafted silica nanoparticles (graft density: 0.30 chains/nm
2
, 252 mg). The reaction was 
stirred at room temperature for overnight. Then the reaction solution was then poured into 
200 mL ethyl ether followed by centrifugation at 3000 rpm for 5 min. The recovered 
particles were then redispersed in 20 mL of ethanol and subjected to dialysis process to 
further remove impurities. The dye-labeled poly(-CD) grafted silica nanoparticles were 






Table 2.1 Measured and corrected diffusion coefficients (D) for various mixtures of C8-
HSL and cyclodextrin. The dissociation constant (Kd) is calculated from equation 2. All 


























H2O C8-HSL /-CD 
10 mM C8-HSL 3.55  13.33    
5.3 mM C8-HSL 
+ 23 mM -CD 
2.00 2.00 13.62 1.96 1.96  
8 mM C8-HSL + 
8 mM  -CD 
2.24 2.04 12.68 2.35 2.14 0.21 
2 mM C8-HSL + 
2 mM -CD 
2.79 1.98 12.79 2.91 2.06 1.49 
3 mM C8-HSL + 
2 mM -CD 
2.88 1.92 12.89 2.98 1.99 1.57 
4 mM C8-HSL + 
2 mM -CD 




Table 2.2 Binding strength of -CD and C6-HSL or C8-HSL as determined by NMR. 
 
 C6-HSL C8-HSL 
Binding constant 0.11 0.69 
Dissociation constant 9.05 1.44 











Table 2.3 Calculated fold change of transcription by V. fischeri after treatment exposures 




no treatment (control) -1.4 4.8 
250 nM -CD -1.7 1.7 
2 mM -CD -97.8 -39.1 
15 nm bare-NPs -250.4 -432.9 
15 nm 155 nM -CD-NPs -245.7 -629.77 
50 nm bare-NPs -1723.4 -365.8 




Table 2.4 Primer sequences used in qPCR. 
 
Gene Forward Primer Reverse Primer 
luxA ATCCCCATCTTCGTGAACGG ACAGAACATGGCCACGACAT 
luxR CGTGGGCGAGTGAAGGAAAA TGGCGCCAGTTAAAATTGCT 





















Figure 2.3 Schematic representation of monolayer -CD coated fluorescent silicon 
dioxide nanoparticles. The black center sphere is the silicon dioxide core, and the white 







H NMR spectra of the as-synthesized -CD coated silica nanoparticles. (a) 





Figure 2.5 TGA of (a) dye-labeled monolayer carboxylic acid coated silica nanoparticles 
(graft density: 0.18 groups/nm
2






Figure 2.6 Schematic representation of a polymer grafted silica nanoparticle with -CD 
side group. Gray center sphere represents the silica core and the white rings enlarged to 

































Figure 2.7 TGA of (a) dye-labeled poly(methacrylic acid) grafted silica nanoparticles 
(graft density: 0.18 groups/nm
2


















Figure 2.10 V. fischeri JB10 cultures in marine broth. Bioluminescence induced with 









Figure 2.11 Maximum relative bioluminescence per OD (600 nm) of V. fischeri during 
exposure to -CD and 2 μM 3OC6-HSL. Error bars represent standard errors of the mean 
(n=3). Asterisk indicates significance (P≤ 0.05). 
  





Figure 2.12 Schematic of nanoparticle-based silencing of bacterial quorum sensing.   
(a) Diagram of V. fischeri lux operon during quorum sensing (QS). Triangles represent 
3OC6-HSL. LuxR/3OC6-HSL complex initiates bilateral transcription of lux operon. 
LuxI produces 3OC6-HSL. Inset: V. fischeri culture flask luminescing after treatment 
with HSLs. (b) Diagram of V. fischeri during nanoparticle treatment. Binding of HSLs by 









Figure 2.13 Changes in bioluminescence by V. fischeri during exposures to 2 μM 3OC6-
HSL, with either -CD or -CD functionalized Si-NPs. Error bars represent standard 









Figure 2.14 Maximum relative bioluminescence per OD (600 nm) of V. fischeri during 
exposure to 2 μM 3OC6-HSL and -CD or -CD functionalized 15 nm polymer 






Figure 2.15 Mean relative bioluminescence per OD (600 nm) of V. fischeri during 
exposure to 125 nM 3OC6-HSL and 0.25 nM C8-HSL treated with 250 nM -CD, bare 
15 nm Si-NPs, 155 nM -CD functionalized 15 nm Si-NPs, bare 50 nm Si-NPs, or 133 
nM -CD functionalized 50 nm Si-NPs. Error bars represent standard error of the mean 










EXTRACELLULAR GLASS WITHIN EPS MATRIX IS A PROTECTIVE 
STRATEGY FOR BIOFILMS AGAINST DESICCATION 
 
Water-limitation and desiccation are common stressors encountered by microbial 
communities at the fringes of aquatic and extreme environments.  Microbes in these 
environments are localized within the protective confines of biofilms surrounded in a 
thick matrix of extracellular polymeric substances (EPS).  Remarkably, desiccated 
biofilms are able to rapidly resume cellular and extracellular activities upon rehydration. 
How this process occurs, however, has remained elusive and constitutes a significant gap 
in understanding resiliency in microbial cells.    
 Here we demonstrate a key step in this process: formation of an EPS glass within 
the anhydrophilic microbial mats of Bahamian salt-ponds. EPS glass formation was 
determined using differential scanning calorimetry (DSC).  The functional integrity of 
key extracellular molecules, called acylhomoserine lactones (AHLs), used in chemical-
signaling and diffusion-sensing, was preserved by vitrification in EPS glass during 
desiccation, and allowed rapid-release and resumption of activity following rehydration. 
AHLs were recoverable from dried mats stored for over seven years, and upon 
rehydration AHLs were determined to be intact and functional using mass spectrometry 
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(MS) and signaling bioassays, respectively. Glasses were formed in vitro using extracted 
components of natural EPS.  The disaccharide α-α-trehalose, an abundant component of 
natural mat EPS, likely contributes in situ to glass formation and AHL stabilization. 
Under laboratory conditions, AHLs were stabilized by trehalose-glasses. Other EPS 
components, however, may additionally contribute to the natural glass as well. Solid-state 
nuclear magnetic resonance (NMR) showed that trehalose stabilizes but does not directly 
complex with AHLs during desiccation.  The results show that preservation of AHLs 
during desiccation provides microbial communities with the capability to resume 
signaling and diffusion-sensing activities soon after rehydration. It is proposed that glass 
formation may play roles in the broader resiliency of microbial life in many 
environments.  
Microorganisms frequently encounter water-limitation and survive desiccation in 
many environments on the Earth’s surface.
468
 These environments exist on the fringes of 
aquatic environments and in extreme environments, such as desert crusts, that have been 
estimated to cover approximately 25% of the Earth’s terrestrial surface.
468
 Survival in 
these environments is often localized within the protective confines of biofilms where 
microbial cells are surrounded by a thick matrix of EPS.   
Desiccation, defined here as the progressive loss of water, is a common stressor 
that occurs with varying magnitude in coastal oceans, as rock varnish, in hypersaline 
ponds, in the far reaches of desert crusts, terrestrial soils, intermittent freshwater ponds 
and streams, and even the Antarctic Dry valleys,
469
 and in the fouling communities of 
sidewalks, buildings, statues, and roof shingles.
470
 The extent of dehydration (to cells) 
varies from environments where water is present much of the time, to environments 
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where water is intermittently present  for only extremely brief periods (e.g., a few hours 
per year). Therefore, the ability of microbial communities to adapt to water-limitation, or 
even complete anhydrobiosis, is likely to be a very widespread process both in the 
present day and throughout the history of life. 
Microbial mats, located within the hypersaline ponds of San Salvador Island, 
Bahamas, and other such environments, face a multitude of stresses such as diel changes 
in temperatures, UV-irradiation, and rapid (minutes) to intermittent (seasonal) osmotic 
challenges. They typically experience a wide range of salinities (10 to 340 ppt), intense 




), high temperatures (> 40
o
C), and chronic nutrient 
depletion.
471
 The mats form well-defined horizontal layers that have previously been 
described.
471-474
 Over an annual cycle, seasonally driven wet/dry conditions typically 
result in a slow evaporation of water in ponds. Highest temperatures and salinities may 
reach greater than 44
o
C and 340 ppt, respectively, during summer, and may be followed 
by partial to complete desiccation. Sudden heavy rainfalls during July and August 
commence the ‘wet season’ and contribute large pulses of freshwater to ponds. Thus, the 
surface microbial mat communities may experience rapid shifts in ionic concentrations 
(300 ppt shift) over a relatively short time interval (e.g. minutes to hours), yet they 
remain metabolically active, and appear well-adapted to these environmental fluctuations. 
 One major adaptation that bacterial communities rely on to develop and survive is 
quorum sensing. Quorum sensing is a communication mechanism that relies on chemical 
signals to regulate essential microbial processes at high cell densities.
475
 The complex 
communities within microbial mats utilize quorum sensing to coordinate gene 
expression.
475
 A common group of chemical signals used by Gram-negative bacteria 
95 
during quorum sensing are the acylhomoserine lactones (AHLs). AHLs contain a lactone 
ring and a long acyl chain, and exist outside of the cells during transit. The length of the 
acyl chain is essential to an AHL’s molecular stability, especially under extreme 
conditions such as high or low pH.
476-477
 While, AHLs are subject to extreme 
environmental conditions,
478
 the EPS may protect and facilitate the transfer of AHLs 
among cells.
479-480
 The persistence of AHLs within an anhydrophilic microbial mat is 
important to understanding the persistence of microbial communities under extreme 
environmental conditions.  
EPS are a common feature of microbial mats, and are especially apparent in 
hypersaline systems.
481
 The EPS contribute a hydrated, but relatively permeable, 
extracellular microenvironment for cells.
482
 This extracellular matrix is thought to 
stabilize cells against rapid fluctuations in ions and nutrients,
483
 and has been shown to 
aid in the desiccation-tolerance of soil bacteria.
484-485
 During the drying process, the EPS 
typically condenses as salinity of the overlying water increases. When salinity reaches 
180-200 g/L the EPS forms a tough, ‘leathery’ surface consistency. This corresponds to 
the greatly reduced ability of ions in the overlying water to exchange with the inner mat 
pore-water (Decho, personal communication).  Finally, the EPS forms a hard, plastic-like 
material that exhibit the properties of an organic ‘glass’ state. Glasses are often formed 
by simple disaccharide sugars, and even polymeric molecules.
486
 They are extensively 
used in dried foods to preserve taste, flavor, and shelf life. The glass state preserves 
important molecules by preventing denaturation in the absence of water.
487
 Interestingly, 
upon the addition of water, these communities of cells, can exhibit a relatively rapid (e.g., 
minutes to hours) recovery from anhydrobiosis.  
96 
At the level of the individual microbial cell(s), previous work has shown that 
osmotic stress may occur through the net loss of water (from cells) and/or from increased 
ionic changes.
482
 As salt stress increases, halophilic or halotolerant microorganisms have 
evolved two basic intracellular pathways in order to compensate: a KCl-type and a 
compatible-solute type of osmoadaptation.
488-489
 Bacteria utilize a range of major 
osmolytes (e.g. glycerol, glycine-betaine, trehalose, glycine, B-glutamate and proline) to 
compensate for increasing osmotic challenges.
482, 490-491
 
An organic glass provides a matrix of very high-viscosity, which retards 
damaging chemical reactions and deleterious physical events, such as fusion and crystal 
formation,
486
 and may stop all chemical reactions that require molecular diffusion.
492
 
Trehalose has a relatively high glass-transition temperature (Tg = 85-120°C) when 
compared to other sugars,
493
 and therefore forms a type of amorphous solid with high 
viscosity, at high temperatures.  
Previous studies have shown that trehalose is commonly utilized intracellularly by 
soil bacteria during periods of drought
494
 in order to maintain membrane stability
495
 and 
preserve the structure of proteins.
496
 Trehalose is a non-reducing disaccharide that 
consists of two glucose molecules linked by an , -1,1-linkage (α-D-glucopyranosyl α-
D-glucopyranosyl), and is often found in EPS.
494
 The very low hydration adjacent to the 
glycosidic oxygen imparts conformational rigidity that allows trehalose to act as a sugar 
template for stable interactions with hydrogen-bonded water molecules.
497
 
In the present study, we have focused specifically on the role of trehalose as an 
extracellular bioprotectant during desiccation, as it is a major component of 
anhydrophilic microbial mats.
471, 474
 A fundamental examination was conducted to 
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understand the role of glass formation in stabilizing certain quorum sensing signals, 
called acylhomoserine lactones (AHLs), during desiccation under natural conditions.  To 
determine the ability of trehalose to protect constituents of microbial mats, we 
additionally studied its role as a bioprotectant of the enzyme acylase. We hypothesized 
that trehalose and other components of EPS may contribute to the enhanced persistence 
of signals and other key extracellular molecules within resident microbial communities.  
 
3.1 RESULTS 
Bacteria and other microbial cells in a wide range of environments often undergo 
reduced water-availability and desiccation. Herein is an examination of the microbial 
mats of hypersaline ponds, which are characterized by a highly diverse and structured 
community of bacteria and archaea within an abundant EPS matrix. These microbial 
communities rapidly regain activity when rehydrated, even after prolonged desiccation. 
EPS plays an important role in this process.  As desiccation ensues, the EPS and 
associated cells on the mat surface condense to form an impervious, leathery-like layer, 
and eventually, a hard, plastic-like layer. The properties of dried mat EPS were examined 
here to understand their role in microbial survival during desiccation.   
 
Analysis of EPS in Salt Pond microbial mat 
 As seen in Figure 1, the desiccation of Salt Pond over time resulted in the 
precipitation of salts on the surface of the mat. Previous studies have shown that the 
salinity and temperature of Salt Pond typically increases throughout the dry season.
498
 
Transition of the surface mats from wet to dry occurs in several steps that are closely 
98 
related to seasonal patterns in precipitation and temperature. During the wet season 
(approx. October-March), active microbial growth occurs in the Salt Pond surface mats 
(Figure 3.1A). As the dry season commences, net loss of water, due to net evaporation 
and higher surface temperatures, result in progressively higher salinities within Salt Pond 
(Figure 3.1B). At high salinities (approximately 170 – 340 ppt), various salts begin to 
come out of solution and co-precipitate on the mat surface. During this period, occasional 
brief rains and wind slowly remove much of the evaporites from the surface, leaving a 
coherent, leathery EPS surface (Figure 3.1C). Examinations with scanning electron 
microscopy (SEM) showed that the surface consists of a continuous 
crystalline/amorphous structure of primarily halite, with lesser amounts of gypsum, 
anhydrite, and other salts (Figure 3.2). Transmission electron microscopy (TEM) 
revealed thick EPS capsules surrounding desiccated cells (Figure 3.3). 
 
Salt Pond EPS has a high abundance of glucose 
EPS plays a critical role in providing structure and protection to the 
microorganisms within a microbial mat (Figure 3.3). Figure 3.4 shows a vertical cross 
section taken from a hydrated microbial mat in Salt Pond. The distinct colors of each 
layer are due to the major constituent of each. The golden polymer layer (L1) is abundant 
in diatoms, the green layer (L2) is abundant in cyanobacteria, and the purple/red layer 
(L3) is abundant in sulfur and nonsulfur purple bacteria.
499
 Although dominated by 
certain species, each layer contains a complex mixture of microorganisms. While each 
layer contains EPS, the polymer layer (L1) contains the highest abundance of EPS. 




 to measure EPS abundance, extending from the high-water region of the pond 
(infrequently covered by water) to the low-water region (covered most of the year). At 
each sample site, the uppermost layer of the microbial mat contained the highest levels of 
EPS (Figure 3.5). The abundance of EPS on the surface of the mat and surrounding 
individual cells may bestow some protection against the extreme environment to the 
underlying mat and its resident microbes, respectively. To better understand the role of 
EPS during desiccation, we investigated the composition of the EPS samples, and 
performed laboratory tests to analyze the carbohydrate components. 
 EPS samples, collected from the Salt Pond microbial mat, were analyzed via gas 
chromatography/mass spectrometry (GC/MS). The GC/MS analysis revealed the 
presence of sugar monomers, including the neutral sugars glucose, galactose, mannose, 
xylose, the 6-deoxyhexoses fucose, rhamnose, and arabinose, the uronic acids 
glucoronate and galacturonate, and N-acetyl-D-glucosamine (Table 3.1). The relative 
enrichment of deoxy-sugars has been shown to increase the hydrophobic nature of some 
EPS.
500
 Methylation, detected in only trace amounts, can influence the conformational 
and physical characteristics of the EPS and their hydrophobicity. In both the hydrated and 
desiccated samples, glucose was found to have the highest mole percentage of the total 
mass. Glucose is often a dominant sugar in EPS.
500-501
 The high concentration of glucose 
may indicate the presence of trehalose, but could not be distinguished in these analyses. 
Trehalose is an ,-1,1-linked disaccharide of glucose, and has been shown to play a role 
in osmoprotection. Osmoprotection is crucial to the survival of microorganisms in 
extreme environments, such as the high salinity and high temperature environment found 
in Salt Pond. 
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Trehalose forms glass in EPS during desiccation 
To study the ability of EPS to form a glass in the microbial mat, and to 
demonstrate the role of EPS as an osmoprotectant, we isolated EPS from Salt Pond. The 
sample was dried and analyzed via differential scanning calorimetry (DSC) and 
thermogravimetric analysis (TGA). Trehalose dihydrate and anhydrous trehalose were 
also dried and used as standards. DSC revealed that both trehalose dihydrate (Figure 3.6) 
and trehalose anhydrous (Figure 3.7) resulted in phase transitions at 85°C, indicating the 
presence of a glass.
493
 DSC also detected phase transitions at the melting points of 
trehalose dihydrate and trehalose anhydrous, as was expected. The DSC analysis of the 
Salt Pond extract revealed that the EPS sample contained several compounds, many of 
which experienced phase transitions (Figure 3.8). Furthermore, TGA confirmed the 
presence of several compounds in the EPS sample, including trehalose dihydrate (Figure 
3.9), as seen in Figure 3.10. The DSC and TGA results verified that the EPS sample 
contained trehalose, and that both trehalose dihydrate and anhydrous trehalose are able to 
form a glass. 
 
C6-AHL subject to degradation in salt water 
The common bacterial quorum sensing signal molecule, N-hexanoyl-L-
homoserine lactone (C6-AHL), is frequently found in microbial mats. To investigate the 
heat tolerance of C6-AHL, it was tested in solution at varying temperatures. The results 
indicated that C6-AHL retained activity at 25, 35, and 45° C. Activity was not detected 
after exposure to 55 or 65° C. Signal activity was determined by the presence of 
pigmentation in the biosensor C. violaceum CV026.  The microbial mat presents a 
complex environment to signal molecules, and therefore the signal molecules may utilize 
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several other components to maintain activity at high temperatures. To explore the role of 
salt in the preservation of C6-AHL, salt water samples from Salt Pond were added to the 
experimental solution. 
Long term (3 days) exposure to 55° C in high salt solutions was tested to 
determine if the natural salt water environment provided protective elements to the signal 
molecule. Water samples collected from Salt Pond in San Salvador, Bahamas were used. 
The C6-AHL was dissolved in small volumes of salt water and dried over the course of 
three days. The initial salt concentrations were 280 ppt, 140 ppt, 70 ppt, and 35 ppt. 
Sodium chloride (NaCl) was used as the control. C6-AHL dried in 28 ppt (normal salt 
concentration of ocean) Salt Pond water retained activity. However, C6-AHL did not 
retain any activity after desiccation at 55° C in solutions of 280 ppt, 140 ppt, 70 ppt, or 35 
ppt Salt Pond water. A qualitative analysis of the water sample from Salt Pond was 
performed via ICP-MS. The analysis showed that the sample contained numerous trace 
metals, including calcium, manganese, and magnesium. Interestingly, C6-AHL dissolved 
in 280 ppt Salt Pond water and stored at room temperature also lost activity after three 
days. 
This experiment was repeated with gentle heating over a longer time period to 
better mimic the microbial mat environment. After heating at 35°C to dryness (five days), 
neither the Salt Pond water samples nor the pure NaCl samples retained C6-AHL activity. 
To ensure that the biosensor was providing accurate results, we used the parent strain of 
C. violaceum to test for quorum sensing inhibitors. Neither the high salt solutions of Salt 
Pond water or NaCl inhibited quorum sensing in C. violaceum. These results indicate that 
C6-AHL activity is dependent on both the temperature and duration of heating. Given the 
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complexity of a microbial mat, we next explored the role of trehalose as an 
osmoprotectant during desiccation. 
 
Trehalose provides protection to C6-AHL during desiccation 
To investigate the heat tolerance of C6-AHL in the presence of trehalose, samples 
were subjected to high heat. Solutions of C6-AHL and trehalose were heated at either 
50°C or 60°C for five days. The 60°C heat treatment was followed by exposure to 100°C 
for 15 minutes to ensure the formation of a trehalose glass. Both experiments were 
conducted at pH 7.5 and pH 11, two conditions commonly found in microbial mats. A 
third component, the enzyme acylase, was also added to the solution to determine if 
trehalose could provide protection to an enzyme during desiccation.  
For the experiment conducted at 50°C, the results indicated that activity of C6-
AHL was maintained after trehalose glass formation with and without acylase at both pH 
7.5 and pH 11. Signal activity was determined by the biosensor C. violaceum CV026, as 
seen in Table 3.2. These results suggested that C6-AHL is tolerant of long term exposure 
to 50°C in the dehydrated state in the presence of trehalose. Interestingly, C6-AHL was 
also tolerant of the pH 11 environment in the presence of trehalose although, typically, 
high pH environments destabilize homoserine lactones. Under these conditions, acylase 
activity was not preserved. 
For the experiment conducted at 60°C and 100°C, the results indicated that C6-
AHL tolerated heat treatment in the presence of trehalose at pH 7.5. However, C6-AHL 
activity was not preserved in the presence of trehalose at pH 11. And, once again under 
both conditions, acylase activity was not preserved. It is likely that the acylase was 
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activated at pH 11, and destroyed the C6-AHL before being degraded by heat. The data is 
presented in Table 3.2. 
To verify the formation of a trehalose glass and to determine if any structural 
changes occurred in the sample, solid state NMR spectroscopy was performed.  As 
before, the samples were subjected to heat treatment at 60°C for five days followed by 
100°C for 15 minutes at pH 7.5. The higher temperature conditions were used in this 
experiment to ensure that all residual water was removed from the samples before 
analysis. The NMR spectra of both heat-treated and untreated trehalose and trehalose 
with C6-AHL can be seen in Figure 3.11. The spectra indicate that the structure of C6-
AHL was not altered by heat treatment with (Figure 3.11B) or without (Figure 3.11A) 
trehalose present. These results correspond with the biosensor data presented in Table 
3.2. As expected, the structure of trehalose was altered by heat treatment, as can be seen 
by comparing Figure 3.11C and Figure 3.11D. The heat treatment of trehalose resulted in 
broad, unresolved resonances due to the highly disordered molecules and amorphous 
state of the glass (Figure 3.11C). The untreated trehalose samples appear highly 
crystalline in structure (Figure 3.11D). In the presence of C6-AHL, the trehalose spectra 
indicated a glass structure (Figure 3.11B). These results suggest that the glassy state of 
the trehalose is not influenced by the presence of C6-AHL. Also, the heat treatment does 
not change the resonances or the structure of C6-AHL in the presence or absence of 
trehalose. The spectra of heat-treated C6-AHL alone (data not shown) was identical to the 
untreated C6-AHL spectra (Figure 3.11A) and the spectra of the heat-treated trehalose 
with C6-AHL (Figure 3.11B). Ultimately, this experiment demonstrated that trehalose 
forms a glass at high temperatures, the structure of which is not influenced by C6-AHL.  
104 
 Together, the C6-AHL assay and the solid state 
13
C NMR spectroscopy illustrate 
that C6-AHL alone was tolerant of the 50°C treatment, but not the 60°C / 100°C 
treatment. The fact that C6-AHL activity was preserved at the higher treatment in the 
presence of trehalose suggests that trehalose plays a role as an osmoprotectant. Given that 
our model relies on a simple system, and lacks the complexity of an environmental 
microbial mat, we further studied the role of divalent cations during glass formation. 
 
Divalent cations stabilize enzyme during desiccation 
 To further analyze the activity of acylase during glass formation, and to determine 
if its activity is being preserved in the model system, an enzymatic assay was performed 
after heat treatment. The initial glass samples containing acylase, described in Table 3.2, 
did not have any enzymatic activity after glass formation. It is known that some enzymes 
within microbial mats are stabilized by interactions with carbohydrates. However, given 
that our system simply mimics a microbial mat, and is lacking several of the key 
components therein, we added a variety of divalent cations in an attempt to further 
stabilize acylase. 
The study found that the presence of manganese at pH 11 during heat treatment 
resulted in high enzymatic activity. At pH 7.5, calcium was most effective at preserving 
enzymatic activity. As seen in Table 3.3, we looked at glucose, trehalose, and dextran, 
and the dissolved cations manganese, magnesium, and calcium. In each case, we found 
that dissolved cation alone with acylase was not enough to preserve activity (data not 
shown). However, in some cases the addition of glucose, trehalose, or dextran during heat 
treatment aided in preserving the activity of acylase. The results of the glass formation 
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experiment and the acylase analysis indicated that several interactions within a microbial 
mat may be responsible for preserving the integrity of these compounds. 
 
C6-AHL loses activity in high salt solutions 
In an effort to mimic the natural microbial environment, the heat tolerance of C6-
AHL was tested in a high salt solution. C6-AHL was dissolved and then dried in salt 
water collected from Salt Pond (280 ppt)  
Trehalose is a common constituent of microbial mats, and is believed to provide 
some protection to small molecules during desiccation. To determine if the presence of 
trehalose aided in the retention of C6-AHL activity during exposure to 55° C, it was 
added to the experimental solution of salt water and C6-AHL. After drying for three days 
at 55° C in the presence of Salt Pond water, NaCl, or deionized water, C6-AHL was 
inactive. 
Once again, the experiment was repeated with gentle heating over a longer time 
period to better mimic the microbial mat environment. The samples were heated at 35° C 
to dryness over the course of five days. The samples were then heated briefly at 55° C to 
remove residual water and force the trehalose to transition to a glass. C6-AHL did not 
retain activity under these conditions (in water, in salt water, or in NaCl) with or without 
trehalose present. Surprisingly, the trehalose did not act as an osmoprotectant in this case. 
These results indicate that the complex microbial mat ecosystem requires other 





Microorganisms have evolved to survive in extreme environments through a 
number of adaptations. Microbial mats consist of a structured, laminated community that 
allows microorganisms to survive and thrive in extreme environments. The hypersaline 
mat system in Salt Pond on San Salvador Island, Bahamas, experiences dramatic seasonal 
shifts in precipitation, ionic concentrations, and water availability. These shifts create an 
extreme environment for the resident microorganisms. Annual rainfall on San Salvador 
Island is approximately 100 cm, and evaporation exceeds precipitation most years. 
Rainfall is dependent on tropical storms, hurricanes, and related cyclical weather patterns. 
Consequently, the majority of precipitation occurs during the months of September and 
October. After the onset of the dry season, large areas of the mats become and remain 
desiccated for much of the year. The water level, salinity, and extent of desiccation for 
Salt Pond mats are therefore, closely linked to rainfall. Salinity is largely dominated by 






 and a wide variety of trace metals. When compared to 
mats in more temperate climates, the San Salvador mats exhibit lower CO2 and N2 
fixation.
471, 474
 The extreme temperature and salinity during the dry season creates a 
hypersaline environment in the microbial mat. Average temperatures reached above 
40°C, with the salinity steadily increasing to 300 ppt throughout the dry season.
498
 There 
are several key components within microbial mats that allow microorganisms to respond 
to these extreme conditions and survive.  
 Foremost, we theorize that the abundance of EPS in the microbial mat acts as a 
physical shield for the lower layers. The image of the dried Salt Pond mat (Figure 3.1) 
shows the thick upper crust of salt that protects the surface of the microbial mat. SEM 
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imaging confirmed that the upper layer of the microbial mat contained crystalline and 
amorphous polysaccharides, both of which provide a physical barrier to UV radiation and 
oxidative damage. Furthermore, we found that EPS was most abundant in the top most 
layer of the mat (Figure 3.5). The EPS of the Salt Pond microbial mat contained a wide 
variety of monosaccharides, most notably glucose. We suggest that the high 
concentration of glucose may be inclusive of a high trehalose concentration. Of the 
polysaccharides, trehalose forms the most stable glass, and is often used by the food 
industry as a preservative and stabilizer.  
 We next investigated the ability of divalent cations to stabilize enzymes during 
desiccation. We found that in the presence of glucose, trehalose, and dextran, calcium 
and manganese enhanced the stability of acylase during heat treatment.  Desiccation 
increases potential for UV damage and oxidative damage; therefore we investigated the 
potential protective elements within the microbial mat. Trehalose is a ,-1,1-linked 
glucose disaccharide that often provides osmoprotection and stability to small molecules. 
Trehalose is a major component of EPS, and is able to form a glass at high temperatures. 
We have observed biological activity in previously desiccated microbial mats after 
periods of rainfall. We theorize that trehalose plays a role in preserving microorganisms 
and small molecules during desiccation and throughout the dry season. Here we have 
provided evidence that trehalose protects the quorum sensing signal molecule C6-AHL at 
high temperatures. Trehalose is able to form a glass at temperatures above 55°C, the 
structure of which does not modify the structure of C6-AHL. Normally, C6-AHL would 
be degraded by high temperatures. Interestingly, we could not demonstrate the protective 
properties of trehalose in the presence of high salts. We theorize that several components 
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may be responsible for the preservation and osmoprotection of C6-AHL during 
desiccation.  
A second compound, acylase, was also investigated in the presence of trehalose. 
We found that acylase was not able to withstand high temperatures, and was not aided by 
the presence of trehalose. However, acylase activity was improved when the enzyme was 
dried in the presence of divalent cations, specifically calcium and manganese. Salt Pond 
contains both of these cations in abundance, and is frequently flooded with sea water, 
where these cations are also present. The polysaccharides of EPS are known to retain and 
stabilize enzymes. Several trace metals are found in Salt Pond water, and may contribute 
to the formation of a protective layer of EPS. 
 
3.3 CONCLUSION 
 This study showed that the formation of an organic glass occurred during 
desiccation of EPS at the Salt Pond microbial mat. Formation of the glass preserved the 
integrity and viability of cells, and the activities of important extracellular signal 
molecules for several years.  Chemical communication is a crucial process guiding 
interactions among bacteria and archaea in hydrated conditions. AHLs were preserved in 
the extracellular microbial glass during dehydration of natural mats and were able to 
commence signaling upon rehydration.  Under laboratory conditions, AHLs were 
protected in the presence of trehalose, a glass-forming disaccharide, which is abundant in 
the EPS of natural mats. Other EPS components may have also contributed the AHL 
preservation. Using solid state NMR, trehalose was shown to undergo a structural change 
and prevent denaturation of AHLs during desiccation. The trehalose/AHL complex 
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‘dissolved’ upon rehydration and allowed AHLs to resume signaling activity. It is 
proposed that glass formation has implications for the broader resiliency of microbial life 
in many environments. 
 Overall, this study suggests that trehalose glass may play an important role in 
preserving the integrity of quorum sensing signals and bacterial enzymes in a high 
salinity anhydrophobic microbial mat.  Further investigations of environmental samples 
and higher complexity laboratory models are needed to fully understand the role of 
trehalose as an osmoprotectant. 
 
3.4 MATERIALS AND METHODS 
Sample Collection: Natural Mats 
All samples were collected from Salt Pond, located near the northeastern end of San 




30' W). Intact mat samples (6 x 6 cm) were 
collected to a depth of approximately 2 cm and then returned to the Grice Research 
Center laboratory on San Salvador Island for further processing. For EPS analyses, the 
samples were sectioned into 1 mm thick slices under a dissecting microscope using sterile 
razor blades. The samples were transferred to 50 mL tubes and extracted (within 1 hour 
of collection) in the laboratory. The EPS sample was extracted with ethanol and dried at 
35°C for several days. 
 
Glass Formation 
Solutions of 0.2 mg of glucose, trehalose, or dextran were prepared in sterile deionized 
water and incubated in open-top glass tubes at 50°C for 5 days on a heating block. Some 
110 
samples contained 0.1 mg N-hexanoyl-L-homoserine lactone (Cayman Chemical, Ann 
Arbor, MI) and/or 200 units acylase I from porcine kidney (Sigma-Aldrich). The first 
experiment was conducted at 50°C for five days to mimic the environment of a natural 
microbial mat.  The second experiment was conducted at 60°C for five days followed by 
15 minutes at 100°C to ensure the formation of a glass.   
 
Solid State NMR Spectroscopy 
Solid state NMR spectroscopy was conducted on samples of treated (glass) and untreated 
(control) trehalose and C6-AHL. Samples were incubated at 60°C for five days, followed 
by 15 minutes at 100°C. The pH of the samples was 7.5.  Solid state 
13
C CP-MAS spectra 
were collected on a Bruker Avance III-HD 500 MHz spectrometer fitted with a 1.9 mm 
MAS probe. The spectra were collected at ambient temperature with sample rotation rate 
of 20 kHz. 1.5 msec contact time with linear ramping on the 
1
H channel and 62.5 
kHz field on the 
13
C channel were used for cross polarization. 
1
H dipolar decoupling was 
performed with SPINAL64 modulation and 145 kHz field strength.  Free induction 
decays were collected with a 27 msec acquisition time over a 300 ppm spectra width with 
a relaxation delay of 1.5s. 
 
Quorum Sensing Signal Detection 
Chromobacterium violaceum CV026 (provided by Professor Robert McLean of Texas 
Tech University) was used to detect N-hexanoyl-L-homoserine lactone (C6-AHL).  Glass 
samples were resuspended in 50 L sterile deionized water and allowed to rehydrate at 
room temperature for 10 minutes.  10 L of this solution was applied to a sterile paper 
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disk on Luria Bertram (30 g/L) agar plates inoculated with C. violaceum CV026.  Plates 
were incubated at 30°C overnight. The production of a violet pigment by the bacteria 
indicated the presence of C6-AHL. 
 
Temperature tolerance of C6-AHL 
5 µM solutions of C6-AHL in water were subjected to 30 minutes of heat at 25, 35, 45, 
55, and 65° C. Signal activity was determined by the biosensor C. violaceum CV026. The 
C6-AHL was dissolved in small volumes of Salt Pond water and dried over the course of 
three days at both 35 and 55° C. The initial salt concentrations were 280 ppt, 140 ppt, 70 
ppt, and 35 ppt. Pure NaCl was used as the control in the same concentrations. The 
experiment was repeated with 1 mM trehalose added to the solutions. 
 
Acylase I Enzymatic Assay 
Acylase I was detected by spectrophotometric analysis according to Mitz & Schlueter 
(1958). Briefly, the decrease in absorbance at 238 nm was observed every minute for five 
minutes for solutions containing the treated (in glass) or pure (control) acylase I and 100 
mM potassium phosphate and 14 nM N-acetyl-L-methionine (Sigma-Aldrich). The 
number of units/mL enzyme was determined by A238nm/min Test - A238nm/min 
Blank)(60)(3)(dilution factor) / (0.019)(0.1). 
 
Glass Experiment with Cations 
Divalent cations were added to solutions of glucose, trehalose, or dextran at pH 7.5 or pH 
11. Samples were comprised of 0.2 mg sugar, 200 units acylase I, and 0.1 mg dissolved 
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cation from either MnCl2⦁4H2O, CaCl2, NaCl, or MgCl2⦁6H2O. Samples were heated in 
open-top glass tubes at 50°C for five days. After incubation, samples were resuspended in 
deionized water and acylase activity was determined spectrophotometrically with the 
aforementioned assay. 
 
DSC, TGA, and ICP-MS 
DSC was performed with a Q2000 Differential Scanning Calorimeter (TA Instruments, 
USA). Approximately 10 mg of sample was loaded into non-hermetic aluminum Tzero 
pans. An empty aluminum pan was used as a reference for all experiments. The heating 
rate was 10° C/min to 300° C under nitrogen flow. TGA characterization was performed 
with a Q500 Thermogravimetric Analyzer (TA Instruments, USA). Approximately 10 mg 
of sample was heated at a rate of 10 °C /min to 950 °C under nitrogen flow. Data were 
recorded by the instrument software.  A qualitative trace metal analysis of water from 
Salt Pond was performed via inductively coupled plasma (ICP) – quadrupole mass 
spectrometry on a Thermo Finnigan Element XR ICP-MS. 
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Table 3.1 Composition of sugar monomers within EPS extracted from natural mats. 
Carbohydrate monomer composition of EPS isolated from the upper layer of microbial 
mat as determined by GC/MS. Values represent mole percentage of total mass. N=2 
 
Monomer Hydrated Desiccated 
Arabinose 4.2 2.1 
Rhamnose 7.6 11.8 
Fucose 10.6 4.9 
Xylose 16.3 13.3 
Glucuronate 7.6 5.5 
Galacturonate 4.7 2.5 
Mannose 9.3 13.7 
Galactose 8.9 17.5 
Glucose 24.4 28.7 
N-acetyl glucosamine 6.2 -- 
Unknown 0.2 -- 





Table 3.2 C6-AHL activity in trehalose as determined by pigmentation response of C. 
violaceum CV026. ‘Yes’ indicates the presence of a violet pigment during bacterial 
growth, which is produced in response to C6-AHL. ‘No’ indicates the absence of a 
response. Samples were incubated at 50°C for five days or 60°C for five days followed 
by 100°C for 15 minutes. 
 
 50°C 60°C/100°C 
pH 7.5   
C6-AHL Yes Yes 
C6-AHL + Acylase I Yes Yes 
   
pH 11   
C6-AHL Yes No 




Table 3.3 Acylase activity in sugar after heat treatment at 50°C for five days at pH 7.5 
and pH 11.  
 
 Glucose Trehalose Dextran 
pH 7.5    
Mn None None None 
Mg None None None 
Ca None Low Low 
    
pH 11    
Mn High High High 
Mg None None None 











Figure 3.1 Natural microbial mats collected from Salt Pond on San Salvador Island, 
Bahamas showing wet- (A) and dry- (B, C) season sections of mat surface. Note 
underlying layer abundant in cyanobacteria during wet season (A). During early dry-
season, evaporites, including gypsum and halite, begin to appear as salinity increases (B), 







Figure 3.2 SEM of dried surface layer of microbial mat. Sample consists of a continuous 
crystalline/amorphous structure of primarily halite, with lesser amounts of gypsum, 






Figure 3.3 TEM of dry, natural microbial mats showing intact cells surrounded by a 





Figure 3.4 Vertical cross-section of microbial mat in Salt Pond showing distinct layering 
of microbial groups. The uppermost surface Layer (L1) is the layer containing abundant 
EPS, diatoms, archaea, as well as salt precipitates (during dehydration); Layer 2 (L2) is 























Figure 3.5 Abundances of EPS isolated from surface layers of hypersaline mat in Salt 
Pond, San Salvador Island, Bahamas. Surface Layer (L1) is the layer containing the salt 
precipitate and polymers; Layer 2 (L2) is the dense green ‘cyanobacteria’ layer; Layer 3 
(L3) is the layer dominated by purple sulfur bacteria. 
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Figure 3.6 DSC thermogram recorded upon heating of trehalose dihydrate at rate of 
10°C/minute. The sample was dried for five days at 35°C prior to analysis. The small 
shoulder at 85°C indicates a discontinuity in heat flow as the sample transitioned to the 
glassy state and absorbed heat (Tg). The large peak corresponds with the melting point of 






Figure 3.7 DSC thermogram recorded upon heating of trehalose anhydrous at rate of 
10°C/minute. The sample was dried for five days at 35°C prior to analysis. The small 
shoulder at 85°C indicates a discontinuity in heat flow as the sample transitioned to the 
glassy state and absorbed heat (Tg). The larger peak corresponds with the melting point of 







Figure 3.8 DSC thermogram recorded upon heating of Salt Pond EPS at rate of 
10°C/minute. The sample was dried for five days at 35°C prior to analysis. The multiple 
shoulders and peaks indicate the transition temperatures (Tg) of multiple compounds. 








Figure 3.9 TGA thermogram of trehalose dihydrate recorded upon heating at rate of 
10°C/minute. The sample was dried for five days at 35°C prior to analysis. The green line 
represents weight loss occurred. The blue line represents the first derivative of the weight 
loss curve. The inflection point, the greatest rate of change on the weight loss curve 








Figure 3.10 TGA thermogram of Salt Pond EPS recorded upon heating at rate of 
10°C/minute. The sample was dried for five days at 35°C prior to analysis. The small 
peak at 300°C corresponds with the peak expected for pure trehalose dihydrate. The blue 
line represents the first derivative of the weight loss curve. The inflection point, the 
greatest rate of change on the weight loss curve (green), is indicated by the peaks of the 





Figure 3.11  Solid state 
13
C NMR spectra of (a) untreated C6-AHL, (b) heat-treated C6-
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